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Individuals diagnosed with cancer experience a high symptom burden that has a 
significant impact on their quality of life and an individualized, community-based Nordic 
pole walking (NPW) program may help to alleviate this. 
The primary objective of this eight-week multi-centred randomized controlled pilot 
study was to assess the feasibility of a NPW program for individuals with stage I-IV non-
small cell lung cancer (NSCLC), prostate cancer, colorectal cancer, and endometrial 
cancer. The secondary objective was to determine the effects of NPW on physical function 
and health-related quality of life (HRQoL). Participants were randomly assigned to either 
the NPW group (one supervised NPW session and up to three independent NPW sessions) 
or the control group (usual daily routine).  
 The pilot study suggests that examining the effects of NPW on individuals 
diagnosed with cancer is feasible with modifications. Recommendations include: 1) 
Recruit participants at hospital cancer centres; 2) Individualize NPW and integrate 
behavioural change techniques into the program; 3) Use pedometers or accelerometers to 
increase the accuracy of measured physical activity levels; and 4) Organize NPW programs 
for individuals with NSCLC alongside programs for individuals with other chronic 
respiratory diseases. Results indicate trends of improved overall physical activity levels 
and HRQoL measures. The NPW group experienced a significant decrease in thigh 
circumference measurements from the baseline assessment (Right Thigh: median 49.4 cm 
(range 8.7); Left Thigh: median 49.0 cm (range 6.0)) to the final assessment (Right Thigh: 
median 48.5 cm (range 6.5); Left Thigh: median 46.3 (range 4.0)) (p<0.05). Significant 
improvement was also found in the NPW group 30-s chair stand test (Baseline: median 
(SD) 10.5 (3.7); Final: median 14.3 (4.2)) (p<0.05). Further research with larger sample 
sizes should be completed to more conclusively determine the impact of NPW. 
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Cancer rates in Canada continue to rise. A cancer diagnosis affects all aspects of an 
individual’s life and much consideration goes into determining the best treatment plan for 
each patient. The most common treatments for solid tumour cancers are surgery, radiation, 
chemotherapy, and palliative care (alone or in combination).  Achieving a cure or remission 
may not always be possible; however, over time advances in medical technology and 
treatment have allowed physicians to help patients live longer after diagnosis. The benefit 
of living longer often comes with cancer and treatment related side effects that significantly 
impact an individual’s health-related quality of life (HRQoL). Some of the side effects that 
patients may experience include fatigue, weakness, weight loss or gain, pain, anxiety, and 
depression. There is a continual search for interventions to help patients manage or 
minimize these side effects. 
Exercise has been recognized for the key role it can play in helping patients with 
cancer manage symptoms. Exercise is not only considered to be safe and beneficial for 
cancer patients with different symptoms (Knols, Aaronson, Uebelhart, Fransen, & 
Aufdemkampe, 2005; Velthuis, Agasi-Idenburg, Aufdemkampe, & Wittink, 2010), but it 
has been acknowledged for its positive impact on HRQoL, fatigue, muscular strength, and 
aerobic fitness (Cramp & Byron-Daniel, 2012; Mishra et al., 2012; Repka et al., 2014). In 
a population with decreased physical activity levels and an increased risk of developing 
other chronic diseases, exercise is vital. Recently, exercise guidelines have been 
established for individuals with cancer by Cancer Care Ontario (Segal et al., 2015) and the 
American College of Sports Medicine (Schmitz et al., 2010). While there is an 
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understanding that incorporating exercise into the lifestyles of those living with cancer is 
important, there remains a lack of knowledge about the most beneficial exercise 
prescription and the long-term effects of exercise. Also, the impact of exercise on 
individuals with certain types of cancer has been studied less than other types (i.e. non-
small cell lung cancer (NSCLC), endometrial cancer, and colorectal cancer) and the 
sustainability of exercise has not been considered. 
There is growing interest in the benefits of Nordic pole walking (NPW) as an 
effective exercise for improving overall fitness. NPW involves walking with a pair of poles 
that are customized to an individual’s height and stride length. Research on NPW has 
shown improvements in functional status, physical activity, HRQoL, and cardiorespiratory 
outcomes of men and women with varying clinical diagnosis (Fritschi, Brown, Laukkanen, 
& Uffelen, 2012a). There is limited research on the effects of NPW and the cancer 
population. Studies that have been conducted focus on individuals with breast cancer. 
Researchers have determined that NPW is a safe form of rehabilitation for individuals with 
breast cancer and that it may help to improve the muscular endurance of the upper body 
(Malicka et al., 2011; Sprod, Drum, Bentz, Carter, & Schneider, 2005). More research on 
the impact of NPW in individuals with other various types of cancer is needed. NPW is a 
low-impact, inexpensive, and practical type of exercise that is easy to incorporate into one’s 
daily lifestyle making it a potentially effective exercise solution for this population. 
Individuals diagnosed with cancer are often considerably deconditioned and incorporating 
the upper body into walking by using the poles, could possibly help to improve this 
population’s overall physical function during daily activities. 
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A pilot study on the feasibility of an eight-week individualized community-based 
NPW program for individuals diagnosed with stage I to IV NSCLC, prostate cancer, 
colorectal cancer, or endometrial cancer was conducted. 
1.2 Statement of the Problem 
 Innovative developments in cancer detection and treatment have allowed 
individuals with cancer to live longer after diagnosis. In Canada, based on 2006 to 2008 
estimates, more than 60% of individuals diagnosed with cancer are expected to survive for 
five years or more (Canadian Cancer Society, 2016). This longer life expectancy, although 
generally positive, may be outweighed by symptoms that individuals with cancer 
experience. According to the American Cancer Society, more than one in four cancer 
survivors have a high symptom burden one year after diagnosis (Shi et al., 2011). 
Symptoms that patients endure (e.g. fatigue, pain, weight loss or gain, weakness, anxiety, 
and depression) impact their HRQoL and therefore careful monitoring and management is 
needed. In considering these symptoms, it is not a surprise that at diagnosis patients with 
cancer are more likely to be inactive than those who never had cancer (Neil, Gotay, & 
Campbell, 2014). Over time a cycle of inactivity and functional decline can continue as 
strength and cardiovascular fitness deteriorate with worsening symptoms. While people 
now live longer with cancer, often their longer lives are wrought with excess fatigue, 
limited function, and low quality. Thus, it becomes essential that we seek ways to both 
prolong and to advance the HRQoL for cancer patients. Exercise is being recognized for 




1.3 Purpose of the Study 
 The purpose of this pilot study was to determine the feasibility of an eight-week 
individualized community-based NPW program for individuals diagnosed with stage I to 
IV NSCLC, prostate cancer, colorectal cancer, or endometrial cancer. NPW has been 
selected as an appropriate exercise for cancer patients because it is a low-impact, 
economical, and a practical form of exercise that can be executed anywhere. In addition, 
using the upper body when walking with the poles emulates the continuous use of the entire 
body and the endurance that is needed during everyday tasks. This pilot study on NPW and 
individuals with various types of cancer is the first of its kind and provides a better 
understanding of how NPW can be applied in a clinical setting with cancer patients. 
1.4 Research Questions 
The primary research question is: 1) What is the optimal design (patient sample, 
instruments) and operational processes to assess the effects of NPW on individuals who 
have been diagnosed with stage I-IV NSCLC, prostate cancer, endometrial cancer, or 
colorectal cancer? Secondary research questions are: 2) How does participating in an eight-
week NPW program affect physical function? and, 3) How does participation in the NPW 
program affect the health-related quality of life (HRQoL) of these individuals? 
1.5 Hypotheses 
The hypotheses are that the NPW program for individuals who have been diagnosed 
with stage I-IV NSCLC, prostate cancer, endometrial cancer, and colorectal cancer would: 
1) be feasible; 2) improve physical function; and 3) improve the HRQoL.  
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1.6 Proposed Research Framework: Pilot Studies 
Pilot studies are conducted to assess feasibility prior to conducting a large-scale 
investigation (Thabane et al., 2010). They are an important step in the research process. 
The purpose of running a pilot study is usually related to trialling a study design and/or 
testing a new instrument, and establishing that investigators understand the research 
protocol and are able to collect data in a consistent manner (Gardner, Gardner, MacLellan, 
& Osborne, 2003). The specific rationale for performing a pilot study can be classified into 
four categories:  
i)   Process: To assess operational processes that take place within the study. 
For example, determining recruitment and retention rates.  
ii)   Resources: To assess any difficulties that may occur related to time and 
budget. For example, the length of time it takes for participants to complete 
the questionnaires.  
iii)   Management: To observe any potential human and data optimization 
problems that may occur. For example, issues that may arise at participating 
centres.  
iv)   Scientific: To assess treatment safety, determine dose levels and response, 
and estimate treatment effect and its variance (Thabane et al., 2010).  
While pilot studies have little to contribute statistically and theoretically, they 
provide extensive understanding of the research process and help to adapt the design and 
operational processes of a full study (Gardner et al., 2003). Clearly identifying feasibility 
objectives and how they will be measured enables researchers to gather more detailed 
information to better evaluate recruitment, randomization, retention, assessment 
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procedures, new methods, and/or the implementation of a new intervention (Leon, Davis, 
& Kraemer, 2011). Carrying out a pilot study increases the probability of conducting a 
successful large-scale randomized controlled trial (RCT), which is important especially 
when stake holders will be committing significant amounts of time and money to the 





























2.0 Literature Review 
2.1 Introduction 
 This section provides an overview of cancer through examining epidemiology, 
pathophysiology, staging, treatments, and the side effects that occur from cancer and 
treatment of it. A brief description of lung cancer, prostate cancer, colorectal cancer, and 
endometrial cancer is provided because these four types of cancer are the focus of this 
project. Recent research on each type of cancer and exercise is then reviewed. Finally, a 
synopsis of the literature on the physical and psychosocial effects of walking and Nordic 
pole walking (NPW) is provided followed by a more specific examination of the literature 
on NPW and individuals with cancer. At this current time, only one study was found 
involving NPW and individuals with lung cancer (Jastrzebski et al., 2015). The remaining 
studies on NPW and cancer have been conducted with individuals diagnosed with breast 
cancer (Fields, Richardson, Hopkinson, & Fenlon, 2016; Fischer et al., 2015; Malicka et 
al., 2011; Sprod et al., 2005). 
2.2 Search Strategy 
The majority of the search strategy concentrated on cancer, exercise, and NPW. 
Articles on exercise and non-small cell lung cancer (NSCLC), prostate cancer, colorectal 
cancer, and endometrial cancer were obtained by entering the MESH terms for each type 
of cancer and exercise into the Cochrane library and PubMed databases. Filters included: 
systematic reviews, review, meta-analysis, humans, and English. For this literature search 
no date restriction was set. Articles that were relevant to the background of the literature 
review were identified. See Figure 1 for specific search details. The articles on NSCLC 
and exercise also included one article (Coats, Maltais, Tremblay, & Saey, 2014) that was 
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received directly from the author, a systematic review (Rodriguez-Larrad, Lascurain-
Aguirrebena, Abecia-Inchaurregui, & Seco, 2014) that was found upon further inquiry into 
the works cited in another review, and a pilot study (Jastrzebski et al., 2015) that involved 
NPW as part of a cancer rehabilitation intervention. The effects of the study by Jastrzebski 

























315 articles; 12 relevant to literature 
(Bade, Thomas, Scott, & Silvestri, 2015; Cavalheri, Tahirah, Nonoyama, Jenkins, & Hill, 
2013; Cheville et al., 2013; Crandall, Maguire, Campbell, & Kearney, 2014; Granger, 
McDonald, Berney, Chao, & Denehy, 2011; Henke et al., 2014; Hoffman et al., 2013; 
Hoffman et al., 2014; Jastrzebski et al., 2015; L. W. Jones et al., 2008; Kuehr et al., 2014; 







116 articles; 3 relevant to literature 








114 articles; 3 relevant to literature 










22 articles; 1 relevant to literature 
(Smits et al., 2015) 
Figure 1. The search strategy for literature on cancer and exercise. 
Note: No date restriction was set for this search. 
Colorectal Cancer: 
("Colorectal Neoplasms"[Mesh]) AND "Exercise"[Mesh] 
Filters: Systematic Reviews; Review; Meta-Analysis; 
Randomized Controlled Trial; Humans; English 
 
Prostate Cancer: 
("Prostatic Neoplasms"[Mesh]) AND "Exercise"[Mesh] 
Filters: Systematic Reviews; Review; Meta-Analysis; 
Randomized Controlled Trial; Humans; English 
 
Endometrial Cancer: 
("Endometrial Neoplasms"[Mesh]) AND "Exercise"[Mesh] 
Filters: Systematic Reviews; Review; Meta-Analysis; 
Randomized Controlled Trial; Humans; English 
Lung Cancer: 
("Lung Neoplasms"[Mesh]) AND "Exercise"[Mesh] 
Filters: Systematic Reviews; Review; Meta-Analysis; 





 A systematic review conducted by Fritschi, Brown, Laukkanen, and Uffelen 
(2012b) was used as a starting point for the literature review on NPW. To update the review 
the search strategy was directly obtained from Fritschi et al. (2012a) and a search of 
PubMed, Cochrane library, EMBASE, SPORTdiscuss, CINAHL, and PEDRO databases 
was conducted up until July 2016 (Figure 2). Two independent reviewers excluded non-
relevant articles by scanning titles and abstracts. A third reviewer was used when reviewers 
did not agree. In total 460 potential articles were identified, 227 duplicate articles were 
found, and 75 articles met the inclusion criteria. Five studies that are relevant to the thesis 
topic of NPW and cancer patients are discussed within the literature review (Fields et al., 
2016; Fischer et al., 2015; Jastrzebski et al., 2015; Malicka et al., 2011; Sprod et al., 2005). 
Two RCTs investigated NPW in the breast cancer population using outcomes similar to 
our study (upper body strength and endurance) (Malicka et al., 2011; Sprod et al., 2005). 
Due to the limited number of studies examining NPW in the cancer population three 
feasibility studies are included. One pilot study as mentioned above, investigates NPW as 
part of the pulmonary rehabilitation program for patients with advanced lung cancer who 
are undergoing chemotherapy treatment (Jastrzebski et al., 2015). Two other feasibility 
studies that investigated similar outcomes (HRQoL, and physical activity levels) are 








NPW Literature Search Conducted from October 2011 to July 2016 
EMBASE 
n = 205 
CINAHL 
n = 46 
PEDRO 
n = 61 
PubMed 





n = 460 potential sources 















n = 75, 1 relevant RCT from updated search,  
1 RCT from systematic review, 3 pilot studies (1 from lung cancer search) 
(Fields et al., 2016; Fischer et al., 2015; Jastrzebski et al., 2015; Malicka et al., 2011; Sprod et al., 
2005) 
 
Figure 2. The search strategy for literature on NPW. 
2.3 Cancer Overview 
2.3.1 Epidemiology of Cancer in Canada 
 
About two in five Canadians will develop cancer in their lifetime and in 2016 it is 
estimated that 202,400 people in Canada will be newly diagnosed (Canadian Cancer 
Society, 2016). Cancer is responsible for 30% of all deaths in Canada making it the leading 
cause of death ahead of cardiovascular disease (Canadian Cancer Society, 2016). Prostate, 
breast, lung, and colorectal cancers are the most commonly diagnosed cancers in Canada 
Inclusion Criteria: 
RCT or CT; adults >18 years old; intervention: program 
with main component where participants NPW; control 
group: exercise program other than NPW, non-exercise 
intervention, or no intervention; outcome: subjective or 
objective measures of physical or psychosocial health; 




(Canadian Cancer Society, 2016). Over the age of 50 years, these four types of cancers are 
expected to make up more than half of all cancers diagnosed in 2016 (Canadian Cancer 
Society, 2016). As the Canadian population continues to grow and age, cancer diagnosis 
rates are expected to rise (Canadian Cancer Society, 2016).  
The cost of cancer treatment in Canada is substantial. Cancer is already considered 
the third most costly disease after cardiovascular and musculoskeletal diseases (de 
Oliveira, Bremner, Pataky, Gunraj, Chan, et al., 2013). In 1998 cancer care in Canada was 
estimated to cost $14.2 billion (de Oliveira, Bremner, Pataky, Gunraj, Chan, et al., 2013). 
A study published in 2013 reviewed the cancer costs in Ontario of 402,399 patients who 
were 19 years of age and older and had been diagnosed with different cancers (de Oliveira, 
Bremner, Pataky, Gunraj, Chan, et al., 2013). The mean post-diagnosis cost (defined by 
date of diagnosis to subsequent 12 months) for the cohort was $25, 914 (95% CI $25, 782 
- $26, 046). The expenses that contributed the most to these costs included: inpatient 
hospital admission (38%), chemotherapy (9%), physician services (9%), and diagnostic 
testing (9%). The post-diagnosis costs related to cancer have continued to increase over 
time due to the development of new expensive treatments. For example, in Ontario from 
1997 to 2007 for patients age 45 years and older the mean costs for lung cancer have 
increased by about 50% (from $15,170 to $34,471) (de Oliveira, Bremner, Pataky, Gunraj, 
Haq, et al., 2013). The economic burden of the disease is a concern for health care in 
Canada. 
2.3.2 Pathophysiology & Staging of Cancer 
 
In the normal physiological processes of the body, cells renew and regenerate every 
day. Cancer occurs when normal cells develop abnormal characteristics during 
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regeneration causing them to proliferate uncontrollably. This process is known as 
carcinogenesis. If cancer is not eradicated, the tumour will eventually spread or metastasize 
from its original location (Pienta, 2009).  
Different types of cancer share common characteristics or hallmarks that allow for 
tumour growth and metastatic development (Hanahan & Weinberg, 2011). These 
hallmarks include: sustaining proliferative signaling, evading growth suppressors, resisting 
cell death, enabling replicative immortality, inducing angiogenesis, and activating invasion 
and metastasis (Hanahan & Weinberg, 2011). However, each type of cancer does have a 
unique phenotype based on the organ from which it originates, the microscopic appearance 
of the cancer cells, and the molecular defects that initiate the cancer.  
Information collected from physical examination, laboratory test results, imaging 
studies, endoscopy, biopsy, observations during surgery, and the microscopic examination 
of tissue help identify the stage of cancer (Canadian Cancer Society, 2017l). Staging 
describes the magnitude and spread of cancer within the body, which helps establish an 
appropriate treatment plan for each patient (Canadian Cancer Society, 2017l). For solid 
tumour cancers, the most common system used for staging is the Tumour, Node, Metastasis 
(TNM) Staging System (Canadian Cancer Society, 2017l). ‘T’ specifies the size of the 
primary tumour and the amount that it has spread to nearby tissues (Canadian Cancer 
Society, 2017l). ‘N’ indicates if the cancer has spread to nearby lymph nodes as well as the 
size of the nodes and the number of lymph nodes with cancer (Canadian Cancer Society, 
2017l). ‘M’ states if the cancer has spread or metastasized to distant organs (Canadian 
Cancer Society, 2017l). Each type of cancer has its own unique TNM system with 
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additional numbers or letters after the T, N, M supplying more specific details (Canadian 
Cancer Society, 2017l).  
After the TNM classification is assigned for a specific cancer, an overall stage from 
0 to IV is used to identify whether the cancer is in the early or advanced stages (Canadian 
Cancer Society, 2017l). An assignment of stage 0 indicates a carcinoma in situ, which 
means that the tumour cells have not invaded the surrounding tissue (Canadian Cancer 
Society, 2017l). Stage I and II is assigned when the cancer is located within the organ or 
area where it began or has spread to a close by structure (Canadian Cancer Society, 2017l). 
This is called a localized spread (Canadian Cancer Society, 2017l). Stage III specifies that 
the cancer has expanded more into a surrounding structure or the regional lymph nodes, 
referred to as a regional spread (Canadian Cancer Society, 2017l). Stage IV denotes that 
the cancer has spread to a distant site in the body, which is known as a metastatic spread 
(Canadian Cancer Society, 2017l).  
2.3.3 Cancer Treatments and Side Effects  
 
 Cancer affects all aspects of an individual’s life and much consideration goes into 
determining an appropriate treatment plan. Achieving a cure or remission for an individual 
diagnosed with cancer may be unlikely or impossible depending on the type of cancer, the 
stage of cancer, the individual’s overall health, or other significant comorbidities 
(Rosmarin, 2009). The benefits and drawbacks of treatment options are discussed between 
the individual and their healthcare team. Some individuals may decide the goal of their 
treatment plan is palliation or relief from the symptoms caused by cancer and others may 
decide to focus on treatment that delays symptoms. 
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The five most common ways that solid tumour cancer is treated are: 1) surgery; 2) 
radiation; 3) chemotherapy; 4) palliative care; and 5) integrated rehabilitative therapies. 
The following is a brief overview of these treatments and the side effects that are associated 
with each. 
2.3.3.1 Surgery 
 When cancer is detected in the early stages of progression, surgery is often the most 
successful option (Rosmarin, 2009). Historically, surgery was the first type of treatment 
used to control and cure cancer (Stewart & Stewart, 2009). Initially, doctors believed that 
radical surgery was necessary for the best possible outcome and this meant that large areas 
surrounding the tumour were removed along with the tumour (Stewart & Stewart, 2009). 
Over time clinical investigators discovered that a more modest approach involving the 
removal of the mass in addition to other treatments, such as radiation or chemotherapy 
provided the same survival and clinical outcomes (Stewart & Stewart, 2009). Surgery may 
also be performed to diagnose cancer, to stage cancer, to remove a discomfort or disability 
caused by cancer, and to insert a device needed for the treatment of cancer (American 
Cancer Society, 2017a).  
The side effects associated with surgery vary depending on the type of surgery 
performed, the location of the surgery, and the overall health of the patient (Canadian 
Cancer Society, 2017h). Improvement in sterile technique and wound control, as well as 
technological advances such as laparoscopy, robotics, and laser surgery have resulted in 
reduced morbidity associated with surgery (Stewart & Stewart, 2009). Some of the long-
term side effects caused by surgery are: pain due to tissue trauma, neurological pain or 
damage that causes numbness or changes in feeling, swelling of a limb due to lymph node 
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removal (lymphedema), and scarring (Canadian Cancer Society, 2017h). These side effects 
can alter a patient’s movement by limiting their range of motion and potentially decreasing 
their strength and balance. 
2.3.3.2 Radiation Therapy 
 Radiation is a localized treatment that impairs cell division by breaking the strands 
of deoxyribonucleic acid (DNA) in the cells of the body (Stewart & Stewart, 2009). It is 
possible for radiation to be administered in various ways including: 1) by an external beam, 
2) by seeds or rods that are implanted (brachytherapy), and 3) by radioisotopes that are 
ingested or injected into the body (Stewart & Stewart, 2009). To ensure the damage to 
DNA is permanent, oxygen needs to be present (Stewart & Stewart, 2009). Therefore, 
radiation has been found to be less effective in some malignant tumours that have outgrown 
their blood supply since these tumours have areas with little oxygen (Stewart & Stewart, 
2009).  
The doses of radiation that a patient receives are measured in grays (Stewart & 
Stewart, 2009). The higher the dose of radiation the better the tumour can be controlled, 
but the risk of complications increases (Stewart & Stewart, 2009). Therefore, radiation 
treatment is often given in smaller doses called fractions because these smaller doses are 
not only more effective against tumour cells, but they are less likely to permanently damage 
the healthy cells (Stewart & Stewart, 2009).  
Although care is taken to minimize the damage of healthy tissue, side effects still 
occur and certain tissues are more sensitive to being exposed to radiation than others 
(Canadian Cancer Society, 2017g). The tissues with rapidly dividing cells are most 
affected, such as skin cells, and cells lining the gastrointestinal tract (Canadian Cancer 
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Society, 2017g). The side effects that a patient experiences depends on numerous factors 
including (but not limited to) the area or organs being treated, the size of the area being 
treated, the type of radiation treatment, the amount of radiation delivered, the treatment 
schedule, the patient’s overall health, and concomitant medications the patient may be 
taking (Canadian Cancer Society, 2017g). Some side effects of radiation may occur during 
treatment while others may occur weeks after the treatment is complete (Canadian Cancer 
Society, 2017g). Common side effects experienced by patients include: fatigue, skin 
reactions, weight loss or gain, nausea, vomiting, loss of appetite, bone marrow suppression, 
reduced bone growth, hair loss in the treatment area, anxiety or depression, and insomnia 
(Canadian Cancer Society, 2017g). There is also a small risk that patients who are treated 
with radiation could develop a second cancer (Canadian Cancer Society, 2017g). 
2.3.3.3 Drug Therapy 
 Drug therapy works to destroy cancer cells, prevent metastases, or to slow down 
cancer cell growth (Canadian Cancer Society, 2017b). Patients may also be given drugs to 
help reduce or relieve the side effects caused by cancer or its treatments (Canadian Cancer 
Society, 2017b). Each type of drug therapy uses a different mechanism to act against cancer 
cells. The various types of drug therapies include: chemotherapy, hormonal drug therapy, 
immunotherapy, targeted therapy, and supportive drug prevention (Canadian Cancer 
Society, 2017b). Chemotherapy is discussed in detail, as it is the most common therapy 
and has the greatest relevance to this study. 
2.3.3.3.1 Chemotherapy 
 Chemotherapy uses a combination of drugs to treat cancer (Stewart & Stewart, 
2009). Due to the heterogeneous nature of tumour cells, cancer can easily overcome the 
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biological mechanism of one drug (Stewart & Stewart, 2009). In order to prevent or 
minimize the development of this drug resistance, a combination of drugs affecting several 
biological mechanisms at once are used to kill the cancer cells (Stewart & Stewart, 2009). 
Chemotherapy is given to the patient orally, intravenously, or by injection (Stewart & 
Stewart, 2009).  
The side effects a patient experiences from chemotherapy drugs varies greatly 
depending on the type of drug, the dose prescribed, how it was administered, and the 
patient’s general health (Canadian Cancer Society, 2017a). Similar to radiation therapy, 
chemotherapy drugs affect the rapidly dividing cells within the body the most, and side 
effects may occur immediately, or in a few days, weeks, or years (Canadian Cancer Society, 
2017a). Side effects that often occur early include nausea and vomiting (Stewart & Stewart, 
2009). Delayed side effects may include lowered blood counts, diarrhea, alopecia, fatigue, 
and weakness (Stewart & Stewart, 2009). Some examples of more rare side effects that can 
occur are kidney failure, lung scarring, and heart failure (Stewart & Stewart, 2009). 
2.3.3.4 Palliative Care 
 Palliative care helps patients manage the psychological and physical symptoms 
associated with cancer to improve their quality of life (Stewart & Stewart, 2009). In 
Ontario, primary care physicians work with patients to establish their needs and goals 
associated with care (Cancer Care Ontario, 2015). Once this is established various services 
are accessed to ensure the patient is as comfortable as possible. Pain and symptom 
management, psychosocial support, spiritual support, hospice care, and end of life support 




2.3.3.5 Integrated Rehabilitative Therapies 
 Other interventions are used along with traditional medical treatment to address the 
physical, emotional, and spiritual needs of patients (Stewart & Stewart, 2009). Some 
examples include naturopathy, acupuncture, meditation, massage therapy, and dietary 
treatment (Stewart & Stewart, 2009). Exercise has also shown to help with symptom-
related management (Knols et al., 2005; Velthuis et al., 2010) and will be discussed in 
detail in section 2.8. While these treatments are not substitutes for standard oncology 
treatment, they can benefit patients immensely by alleviating the side effects and improving 
HRQoL (Stewart & Stewart, 2009). For example, yoga may help a patient’s mood, and 
acupuncture may help to reduce pain (Stewart & Stewart, 2009).  
2.4 Lung Cancer 
Lung cancer accounts for 14% of all cancer cases diagnosed in Canada, making it 
the most commonly diagnosed type of cancer (Canadian Cancer Society, 2016). It is also 
the leading cause of cancer related deaths in Canada (Canadian Cancer Society, 2016). 
About 20,800 people were expected to die of lung cancer in 2016: more than breast, 
prostate, and colorectal cancers combined (Canadian Cancer Society, 2016).  
Lung cancer is a malignant tumour that originates in the cells of the lungs (Canadian 
Cancer Society, 2017d). Individuals who have been exposed to tobacco smoke, asbestos, 
and radiation are at increased risk of developing lung cancer (Canadian Cancer Society, 
2017f). Most people diagnosed with lung cancer are asymptomatic, however common early 
signs of lung cancer include a persistent cough, hemoptysis (the coughing up of blood), 
chest pain (that is worse with deep breathing, laughing, or coughing), hoarseness, weight-
loss, shortness of breath, wheezing, general weakness or fatigue, and infections such as 
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bronchitis or pneumonia that do not get better (American Cancer Society, 2017b). 
Lung cancer is classified as either small cell lung cancer or NSCLC. Small cell lung 
cancer originates in the bronchi in the centre of the lung and is the most aggressive of all 
types of lung cancer because it usually results in metastases to other parts of the body 
(Canadian Cancer Society, 2017j). It comprises approximately 10% to 15% of all lung 
cancer cases (Canadian Cancer Society, 2017j).  
Non-small cell lung cancer is the most common type of lung cancer accounting for 
85% to 90% of all cases (Canadian Cancer Society, 2017e). There are three main types of 
NSCLC: 1) adenocarcinoma (usually begins in the periphery of the lung), 2) squamous cell 
carcinoma (almost always found in people with a history of smoking and is usually located 
in the large bronchi near the centre of the lung) and, 3) large cell carcinoma (least common 
type of NSCLC) (Canadian Cancer Society, 2017e). An individual with NSCLC has a 
better prognosis the earlier they are diagnosed and treated (Canadian Cancer Society, 
2017e). 
Upon diagnosis, NSCLC is classified based on the extent of cancer in the body 
using the TNM system. The following descriptions of each stage can be applied to most 
NSCLC diagnosis: i) Stage I: Tumours are less than 3 centimeters in diameter and are 
completely within the lung. ii) Stage II: Tumours have metastasized to the bronchial or 
hilar lymph nodes. iii) Stage III: Tumours have metastasized to the mediastinal lymph 
nodes. iv) Stage IV: Tumours have metastasized to the pleura, the other lung, or to other 
organs outside of the chest (Canadian Cancer Society, 2017k).  
Treatment for lung cancer includes lung resection, chemotherapy, radiation 
therapy, or a combination thereof (Canadian Cancer Society, 2014). The treatment 
21 
 
provided will depend on an individual’s stage of cancer, health history, and functional 
ability. On average, 17% of patients diagnosed with NSCLC will survive for at least five 
years (Canadian Cancer Society, 2017m). For those diagnosed with small cell lung cancer, 
lung resection is rarely an option and median survival rates range from 16 to 24 months for 
limited stage cancer and six to 12 months for extensive stage cancer (Canadian Cancer 
Society, 2017j). This research project included patients who have been diagnosed with 
NSCLC because of its higher prevalence and survival rate. 
2.5 Prostate Cancer 
 Prostate cancer occurs when a malignant tumour begins to grow in the cells of the 
prostate, usually in the glandular cells, which make part of the seminal fluid (Canadian 
Cancer Society, 2017t). Most often this type of cancer is slow growing, and can be treated 
successfully (Canadian Cancer Society, 2017t). In Canada, males are more likely to be 
diagnosed with prostate cancer than any other type of cancer with one in eight expected to 
be diagnosed in their lifetime (Canadian Cancer Society, 2016). In 2016 in Canada, 21,600 
individuals were expected to be diagnosed with prostate cancer, accounting for 21% of all 
newly diagnosed cancer cases in males (Canadian Cancer Society, 2016). 
 The common signs and symptoms of prostate cancer include changes in bladder 
habits such as the need to frequently or urgently urinate, blood in the urine or semen, and 
painful ejaculation (Canadian Cancer Society, 2017i). The prostate-specific antigen (PSA) 
test is used to diagnose prostate cancer and monitor a patient’s response to treatment 
(Canadian Cancer Society, 2017c). PSA is a protein that is made by the prostate and it is 
also a tumour marker (Canadian Cancer Society, 2017c). High amounts of PSA in the blood 
can indicate the presence of prostate cancer (Canadian Cancer Society, 2017c). Active 
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surveillance, surgery, radiation therapy, hormonal therapy, and chemotherapy are 
treatment options available for patients with prostate cancer (Canadian Cancer Society, 
2017q). 
2.6 Colorectal Cancer 
A malignant tumour that begins to grow in the cells of the colon or rectum is known 
as colorectal cancer (Canadian Cancer Society, 2017s). The gland cells that produce mucus 
to help the stool move through the colon are where the cancer cells usually start to develop 
and in the early stages individuals may not experience any symptoms because the tumour 
is very small (Canadian Cancer Society, 2017s). Diarrhea, constipation, blood in the stool, 
changes in the look of stool, gas, bloating, and weight loss are some of the signs and 
symptoms of colorectal cancer (Canadian Cancer Society, 2017n). Bowel resection, 
radiation therapy, chemotherapy, targeted drug therapy, or a combination thereof may be 
used to treat colorectal cancer (Canadian Cancer Society, 2017r). 
Colorectal cancer accounts for 13% of all cancers making it the second most 
common type of cancer in Canada (Canadian Cancer Society, 2016). Obesity, physical 
inactivity, consumption of red and processed meats, and smoking are a few of the 
modifiable risk factors that have been associated with colorectal cancer (Canadian Cancer 
Society, 2016). 
2.7 Endometrial Cancer 
  Endometrial cancer starts when malignant cells grow in the uterus (Canadian 
Cancer Society, 2017u). The two main types of endometrial cancer are endometrial 
carcinoma (abnormal cell growth that begins in the endometrium) and uterine sarcoma 
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(cancerous growth that begins in the supportive tissues of the uterus) (Canadian Cancer 
Society, 2017u).  It is estimated that endometrial cancer accounted for 6.6% of all newly 
diagnosed cancer cases in females in 2016 (Canadian Cancer Society, 2016). Between the 
years 2005 to 2010 the incidence of endometrial cancer increased by 2.5% in Canada and 
the United States of America (Canadian Cancer Society, 2016). Risk factors include, but 
are not limited to exposure to increased estrogen, obesity, genetic predisposition, diabetes, 
and endometrial hyperplasia (Canadian Cancer Society, 2016). Abnormal vaginal bleeding 
including changes in menstruation, bleeding between periods, bleeding after menopause, 
and spotting, is the most frequent symptom of endometrial cancer (Canadian Cancer 
Society, 2017o). Endometrial cancer is treated by surgery, radiation therapy, hormone 
therapy, or chemotherapy (Canadian Cancer Society, 2017p). 
2.8 Exercise and Cancer 
As previously mentioned exercise can play a crucial role in helping individuals 
diagnosed with cancer. Before progressing further on this topic, the difference between 
“physical activity” and “exercise” will be explained. Physical activity is defined by 
Caspersen, Powell, and Christenson (1985, p. 126) as “any bodily movement produced by 
skeletal muscles that results in energy expenditure.” Exercise is a subcategory of physical 
activity. Exercise is known as “physical activity that is planned, structured, repetitive, and 
purposive in the sense that improvement or maintenance of one or more components of 
physical fitness is an objective” (Caspersen et al., 1985, p. 128). This review summarizes 
the effects of exercise on individuals diagnosed with cancer focusing specifically on 
NSCLC, prostate cancer, colorectal cancer, and endometrial cancer. 
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Exercise is safe and beneficial for individuals with various symptoms caused by 
cancer and cancer-related treatments (Knols et al., 2005; Velthuis et al., 2010). 
Encouraging exercise in this population is important because many individuals with cancer 
are at an increased risk of developing other chronic diseases such as diabetes and heart 
disease. Additionally, epidemiological studies have shown that sedentary lifestyle and 
obesity impact tumour development (Inoue et al., 2008; Mai et al., 2007; Martinez et al., 
1997). The cardiovascular and fatigue improvements following rehabilitative exercise have 
been shown irrespective of cancer type (Repka et al., 2014). A Cochrane review by Cramp 
and Byron-Daniel (2012) of 56 studies, with 4068 participants, established that aerobic 
exercise is beneficial for individuals with solid cancer tumours who experience cancer-
related fatigue during and post-cancer treatment. This is important since 70% to 100% of 
the cancer population has reported experiencing this debilitating type of fatigue that affects 
an individual physically, emotionally, and mentally, interfering with their activities of daily 
living (Mock, 2001). Furthermore, another Cochrane Review that included 40 trials, with 
3694 participants, reported that exercise had a positive impact on HRQoL, including 
cancer-specific concerns, body image and self-esteem, emotional well-being, sexuality, 
sleep disturbance, social functioning, anxiety, fatigue, and pain (Mishra et al., 2012). 
Research is still needed to determine the most effective type of exercise (according to 
mode, intensity, frequency, duration, and timing) for optimal HRQoL and to determine 
how the positive effects of exercise can be sustained over time (Cramp & Byron-Daniel, 
2012; Mishra et al., 2012). 
 Exercise guidelines have been created by Cancer Care Ontario (Segal et al., 2015) 
and the American College of Sports Medicine (Schmitz et al., 2010) for adults living with 
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cancer who are undergoing treatment or who have completed treatment. The 
recommendations of both organizations are similar with minor variations. The suggested 
duration, frequency, and intensity include 150 minutes of moderate-intensity aerobic 
exercise over three to five days, along with resistance training (involving major muscle 
groups) at least twice during the week (Schmitz et al., 2010; Segal et al., 2015). Exercise 
is recognized as being safe for this population and essential for the long-term physical and 
psychological health (Schmitz et al., 2010; Segal et al., 2015). It is recommended that 
individuals living with cancer incorporate moderate intensity exercise into their lifestyle to 
see improvements in quality of life, muscular strength, and aerobic fitness (Schmitz et al., 
2010; Segal et al., 2015). 
2.8.1 Exercise and Lung Cancer 
Exercise interventions for patients with NSCLC pre- and post-surgery have been 
determined to be safe, feasible, and well tolerated, even in those with advanced and 
metastatic disease (Crandall et al., 2014; Hoffman et al., 2013; L. W. Jones et al., 2008). 
Additionally, low to moderate intensity aerobic, resistance, and balance exercises were 
found to be well tolerated in patients with NSCLC who underwent chemotherapy and/or 
radiation treatment (Hoffman et al., 2014; Kuehr et al., 2014). Recent reviews of exercise 
in lung cancer report that exercise has been shown to reduce symptoms, increase exercise 
tolerance, improve HRQoL, and potentially reduce length of stay and post-operative 
complications (Bade et al., 2015; Coats et al., 2014). Much of the evidence in NSCLC to 
date has focussed on exercise in the perioperative and advanced stages. 
2.8.1.1 Perioperative Exercise 
In 2013, a Cochrane review identified three randomized controlled trials (RCTs) 
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involving 178 participants who took part in an exercise intervention within 12 months of 
lung resection for NSCLC (Cavalheri et al., 2013). The review found exercise capacity, as 
measured by the six-minute walk test (6MWT), was significantly greater in the intervention 
group compared to the control group (mean difference (MD) 50.4m; 95% confidence 
interval (CI) 15.4 to 85.2m) (Cavalheri et al., 2013). There was no reported difference in 
HRQoL between groups  (Cavalheri et al., 2013). Authors noted that the results of this 
review should be interpreted with caution due to the limited number of RCTs and 
significant risks of bias associated with small sample sizes, lack of blinding, and 
performance bias (Cavalheri et al., 2013). The quality of evidence in this research area is 
negatively affected by the limited number of RCTs that have been done (Cavalheri et al., 
2013). 
Three other systematic reviews investigated the effect of exercise in the NSCLC 
population (Crandall et al., 2014; Granger et al., 2011; Rodriguez-Larrad et al., 2014). In 
the systematic review by Granger et al. (2011) (n=675, 2 RCTs, 8 observational studies) 
interventions included aerobic training, resistance training, stretching exercises, or a 
combination thereof and outcomes included exercise capacity, HRQoL, and safety. 
Overall, NSCLC patients benefited from exercise interventions pre-operatively or post-
cancer treatment (surgery, chemotherapy, and/or radiation) evidenced by significant 
improvements in exercise capacity (6MWT distance or peak oxygen consumption 
(VO2peak)) (Granger et al., 2011). Some domains of HRQoL were positively affected 
(Granger et al., 2011). Exercise was also found to be safe for NSCLC patients before and 
after cancer treatment (Granger et al., 2011).  
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Crandall et al. (2014) completed a systematic review (n=575, 8 RCTs, 10 single 
group trials) on exercise interventions for lung cancer patients who were surgically treated. 
Studies included in this review involved exercise interventions that were supervised or 
unsupervised inpatient, or community or home-based outpatient (Crandall et al., 2014). 
Researchers concluded that exercise led to improved cardiopulmonary exercise capacity, 
increased muscle strength, reduced fatigue, decreased post-operative complications, and 
shorter hospital length of stay in patients with resectable NSCLC (Crandall et al., 2014). 
Three RCT’s measured the effects of post-operative exercise programs on HRQoL and 
found no significant difference between groups. However, differences in HRQoL 
measurement tools (generic/specific), intervention designs, and the extent of surgery made 
comparison between studies difficult (Crandall et al., 2014). Future studies should use 
similar measurement tools that have demonstrated reliability and validity within the 
specific patient population (Crandall et al., 2014).  
Rodriguez-Larrad et al. (2014) conducted a systematic review (n=599, 8 RCTs) 
examining the use of perioperative respiratory physiotherapy in patients who underwent 
pulmonary resection for lung cancer. Interventions included chest physiotherapy or 
intermittent positive pressure breathing only, with or without aerobic and resistance 
training (Rodriguez-Larrad et al., 2014). Each study included in the review examined at 
least two or more of the following outcome variables: functional capacity, postoperative 
pulmonary complications (PPC), or length of hospital stay (LOS) (Rodriguez-Larrad et al., 
2014). Pre-operative aerobic exercise in patients undergoing lung cancer resection was 
found to improve functional capacity and reduce postoperative morbidity (e.g. pneumonia, 
or respiratory complications requiring addition ventilatory support) (Rodriguez-Larrad et 
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al., 2014). The addition of aerobic and resistance training to the usual care or standard 
physiotherapy in the post-operative period did not reduce PPC or LOS in patients 
undergoing lung resection (Rodriguez-Larrad et al., 2014). These results should be taken 
with caution because of the high variability in the types of interventions used; it was not 
possible to establish the effectiveness of each individual intervention (Rodriguez-Larrad et 
al., 2014).  
To summarize, evidence indicates that perioperative exercise is safe and may 
benefit the exercise capacity and HRQoL of lung cancer patients. Due to significant 
between-study heterogeneity within the systematic reviews, it was not feasible to conduct 
meta-analyses and pool results (Crandall et al., 2014; Granger et al., 2011; Rodriguez-
Larrad et al., 2014). Future research should continue to analyze various types of exercise 
in order to inform health care professionals of the optimal exercise prescription and setting 
for NSCLC patients. In addition, larger sample sizes, clear reporting structure, and 
adequate allocation concealment should also be considered. 
2.8.1.2 Advanced Disease and Exercise 
Lung cancer patients with advanced stages (III or IV) of NSCLC have notably 
decreased exercise capacity due to decreased pulmonary function and peripheral muscle 
strength (Yilmaz et al., 2013). This reduced exercise capacity negatively impacts the 
functional categories of HRQoL in these patients (Yilmaz et al., 2013). The combination 
of symptoms, including diminished muscle strength, decreased HRQoL, increased 
dyspnea, and greater levels of fatigue provide a strong rationale for referring this patient 
population to a formal exercise program such as pulmonary rehabilitation (Holland, 
Wadell, & Spruit, 2013).  
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In 2013, a RCT (n=66) examined the effects of a home-based walking and strength 
training exercise program (versus usual care) on physical function, fatigue, and sleep 
quality in patients with stage IV lung and colorectal cancer (Cheville et al., 2013). Twenty 
out of 26 of the participants in the intervention group adhered to the program (Cheville et 
al., 2013). They showed significant improvements in mobility, fatigue, and sleep quality 
over time (Cheville et al., 2013). Henke et al. (2014) also conducted a RCT (n=46) to test 
the effects of strength and endurance training on functional capacity (6MWT distance and 
staircase walking), muscle strength (maximum number of repetitions doing a bicep curl, 
tricep extension, bridging, and abdominal exercise), the independence in carrying out 
activities of daily living, and HRQoL of lung cancer patients with advanced disease during 
three cycles of palliative chemotherapy treatment (Henke et al., 2014). The intervention 
group (n=18) participated in cardiovascular exercise daily and strength training every other 
day; the control group (n=11) received conventional physiotherapy consisting of manual 
therapy and breathing techniques (Henke et al., 2014). Out of 46 patients only 29 completed 
the trial (patients died (n=6), were non-compliant (n=10) or they continued treatment at a 
different hospital (n=1)) (Henke et al., 2014). Of those who completed the trial, there was 
a significant difference between groups in patient’s independence in activities of daily 
living, self-reported symptoms (pain, neuropathy, cognitive functioning, dyspnea), and 
exercise capacity (both functional capacity and muscle strength) (Henke et al., 2014).  
As mentioned earlier, cancer-related fatigue is a disabling symptom that often 
interferes with an individual’s activities of daily living particularly in those who are 
diagnosed with advanced stage cancer. Paramanandam and Dunn (2014) conducted a 
detailed literature review (n=192, 9 prospective single group intervention studies, 1 case 
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study) examining the influence of exercise on cancer-related fatigue experienced by lung 
cancer patients. Exercise interventions were all supervised and included aerobic exercise 
(including interval training), resistance training, a combination of both aerobic and 
resistance training, and breathing and mobility exercises (Paramanandam & Dunn, 2014). 
The intensity, frequency, and duration of exercise programs varied greatly (Paramanandam 
& Dunn, 2014). All studies showed some improvement in fatigue with three out of ten of 
the studies reporting a significant reduction in fatigue (Paramanandam & Dunn, 2014). The 
findings of these studies are limited by the lack of control groups and small sample sizes 
(Paramanandam & Dunn, 2014). The clinical application of results is reduced due to the 
substantial variation in exercise interventions, and participants included in the study 
(Paramanandam & Dunn, 2014). Evidence from the review may support the use of exercise 
in the management of cancer-related fatigue experienced by lung cancer patients, however 
studies of higher methodological quality are needed to substantiate this finding 
(Paramanandam & Dunn, 2014). 
Overall, evidence suggests that exercise capacity and symptom burden in patients 
with advanced lung cancer can be improved with exercise; however, optimal mode, 
frequency, duration, and intensity of prescription have not been established. Most studies 
on exercise in this population have consisted of in-hospital supervised exercise programs, 
which may be restrictive to some patients and has been associated with poor compliance. 
Home or community-based exercise programs including new modalities of exercise may 
be more accessible and feasible for this patient population (Coats et al., 2013). 
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2.8.2 Exercise and Prostate Cancer 
 The prognosis of individuals with prostate cancer can vary greatly depending on 
the severity of disease and the general health of the individual at diagnosis, but most often 
patients with prostate cancer are long-term survivors (Menichetti et al., 2016). The HRQoL 
of prostate cancer survivors is effected by their medical and psychological needs as they 
age. It is important to understand how exercise may benefit these individuals and help to 
improve their HRQoL. Three systematic reviews have explored the effect of exercise on 
individuals with prostate cancer (Hasenoehrl et al., 2015; Menichetti et al., 2016; Teleni et 
al., 2016).  
Menichetti et al. (2016) reviewed 17 RCTs (n = 1989) that explored the effect of 
lifestyle interventions (including exercise, dietary, or behavioural components) on the 
HRQoL of individuals with prostate cancer. The duration of the interventions ranged from 
four to 96 weeks (median 12 weeks) and most studies included participants that received a 
specific type of treatment, including androgen deprivation therapy (ADT) (8 studies), 
radiation (3 studies), active surveillance (1 study), radical prostatectomy (1 study), or 
radiation in addition to ADT (1 study) (Menichetti et al., 2016). Two studies involved 
patients who had multiple active treatment options and one study included patients with a 
wide range of treatment conditions (Menichetti et al., 2016). Most interventions reported 
significant improvements in quality of life outcomes (59%) (Menichetti et al., 2016). 
Exercise interventions were found to have the greatest number of positive results on quality 
of life outcomes (67%), compared to dietary interventions (50%), and mixed lifestyle 
interventions (33%) (Menichetti et al., 2016). In particular, resistance training over 12 or 
24 weeks resulted in significant improvement in patients’ quality of life (Courneya et al., 
2004; Segal et al., 2003) and other outcomes, such as sexual functioning (Cormie, Newton, 
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Taaffe, et al., 2013), fatigue (Segal et al., 2003), and physical functioning (Courneya et al., 
2004; Galvao et al., 2014; Galvao, Taaffe, Spry, Joseph, & Newton, 2010; S. W. Park et 
al., 2012). The results of this systematic review are supported by two other RCTs. Monga 
et al. (2007) found that an eight-week cardiovascular intervention with individuals who 
were receiving radiation for prostate cancer (n=21) improved cardiovascular fitness, 
flexibility, muscle strength, overall HRQoL, and prevented fatigue. Segal et al. (2009) 
compared cardiovascular training and resistance training in 121 patients starting radiation 
with or without ADT. Both cardiovascular training and resistance training groups 
improved, yet the improvements in the resistance training group lasted longer (Segal et al., 
2009). 
A systematic review by Teleni et al. (2016) examined seven RCTs (n=585) that 
investigated the effect of exercise on HRQoL, ADT symptoms, and/or metabolic risk 
factors in individuals with prostate cancer treated with ADT. Individuals receiving ADT 
may experience side effects such as vasomotor distress, depression, anxiety, mood swings, 
poor sleep quality, and compromised sexual function (Teleni et al., 2016). This treatment 
also causes individuals to be more likely to develop metabolic conditions (e.g. diabetes, 
cardiovascular disease, abdominal obesity, and osteoporosis) (Teleni et al., 2016). RCTs 
included in the review examined a combination of resistance training and aerobic training 
(4 studies) (Bourke et al., 2011; Bourke et al., 2014; Galvao et al., 2014; Galvao et al., 
2010), resistance training only (2 studies) (Culos-Reed et al., 2010; Segal et al., 2009), 
aerobic training only (1 study) (Alberga et al., 2012; Segal et al., 2009), and football 
training sessions (1 study) (Uth et al., 2014). In the studies that involved aerobic training, 
intensity ranged from 55% to 85% of maximal heart rate or 11 to 15 points on the Borg 
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Rate of Perceived Exertion (RPE) Scale (Teleni et al., 2016). Intensity was not reported in 
most of the resistance training studies, for those that did, participants trained at 60% to 
70% of one repetition maximum (Teleni et al., 2016). Exercise was found to significantly 
improve HRQoL (n= 427, 5 studies) (Alberga et al., 2012; Bourke et al., 2011; Culos-Reed 
et al., 2010; Galvao et al., 2014; Galvao et al., 2010) and disease-specific quality of life (3 
studies, n= 271(Alberga et al., 2012; Bourke et al., 2011; Bourke et al., 2014) in men 
undergoing ADT. However, the effect size of exercise on these outcomes was small to 
moderate, and because most of the studies involve a combination of resistance and aerobic 
training, it was not possible to determine whether one type of training or a combination of 
the two was more beneficial (Teleni et al., 2016). No studies included in the review on 
exercise examined the effect on ADT symptoms and/or metabolic risk factors (Teleni et 
al., 2016). Total body weight, waist to hip ratio, waist circumference measures, and body 
composition measures did not significantly improve with exercise (Teleni et al., 2016). 
Similarly, exercise did not significantly improve systolic blood pressure, blood glucose 
levels, total cholesterol, triglycerides, LDL cholesterol, or HDL cholesterol (Teleni et al., 
2016). Teleni et al. (2016) acknowledge that more research on the optimal exercise type, 
intensity, and duration is needed. Also, future trials are needed to determine an intervention 
that is effective in reducing the symptoms of ADT and managing metabolic risk factors 
(Teleni et al., 2016). 
 Hasenoehrl et al. (2015) conducted a systematic review to understand the effects of 
resistance exercise on the management of side effects experienced by individuals with 
prostate cancer who were receiving or had received ADT. Thirteen trials (n=876), many of 
which were included in the systematic review by Teleni et al. (2016), were included in the 
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review (Bourke et al., 2011; Bourke et al., 2014; Cormie et al., 2015; Cormie, Newton, 
Spry, et al., 2013; Galvao et al., 2006; Galvao et al., 2014; Galvao et al., 2010; Hanson et 
al., 2013; S. W. Park et al., 2012; D. Santa Mina et al., 2013; Segal et al., 2003; Segal et 
al., 2009; Winters-Stone et al., 2014). Exercise interventions ran for 12 to 52 weeks and 
exercise prescription varied greatly (Hasenoehrl et al., 2015). Some studies included a 
combination of resistance training and aerobic training, while others focused only on 
resistance training (Hasenoehrl et al., 2015). Hasenoehrl et al. (2015) concluded that 
resistance exercise was safe and successful in improving muscular strength and 
performance as well as fatigue and HRQoL. Similar to the Teleni et al. (2016) systematic 
review, there was inadequate evidence to determine if resistance training improved 
cardiovascular performance, body composition, blood lipids, bone mineral density, and 
immune response (Hasenoehrl et al., 2015). 
Research indicates that exercise interventions are feasible and safe for individuals 
with prostate cancer during and after various types of treatment. Both aerobic and 
resistance exercise have been shown to improve physical performance capacity and 
HRQoL. Future studies are needed to determine optimal exercise type, duration, frequency, 
and intensity to reduce symptoms and manage metabolic risk factors in this population. 
2.8.3 Exercise and Colorectal Cancer 
 A review article by Halle and Schoenberg (2009) provides some insight into the 
research that has been conducted on the effects of exercise on individuals with colorectal 
cancer. Epidemiological investigations and prospective cohort studies have shown that 
men and women who participate regularly in exercise have a decreased risk of developing 
colon cancer (Halle & Schoenberg, 2009). A study of 150,000 people (70,403 men and 
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80,771 women; median age of 63 years) determined that an individual’s risk of developing 
colon cancer decreased significantly as the number of hours of exercise participation 
increased per week (Chao et al., 2004). In fact, individuals who exercised for over 7 hours 
each week had a 40% decreased risk of colon cancer  (Chao et al., 2004). Three prospective 
studies on lifestyle changes and disease outcomes have shown that exercise can also 
improve the prognosis of individuals with colon cancer, even in those with advanced stage 
disease (Haydon, Macinnis, English, & Giles, 2006; Haydon, Macinnis, English, Morris, 
& Giles, 2006; Meyerhardt, Giovannucci, et al., 2006; Meyerhardt, Heseltine, et al., 2006). 
The effect of exercise on rectal cancer is inconsistent (Halle & Schoenberg, 2009), with 
some studies indicating risk reduction with increased levels of exercise, while other studies 
do not (Halle & Schoenberg, 2009). 
 Backman et al. (2014) conducted a randomized pilot study examining the feasibility 
and adherence of regular walking among 71 breast (n=54) and colorectal (n=17) cancer 
patients undergoing chemotherapy. Over 10 weeks the intervention group (breast n=27, 
colorectal n=8) aimed to walk 10,000 steps a day and participate in a weekly supervised 
group walk while the control group did not (Backman et al., 2014). Adherence averaged 
91% during the intervention period and was measured by how many participants reported 
the steps they took each day (Backman et al., 2014). The majority of the intervention group 
completed the 10-week intervention and these participants averaged 8300 steps per day, 
with 34% of participants reaching the step goal of 10,000 steps per day every week 
(Backman et al., 2014). It was feasible for individuals with breast and colorectal cancer 
who were receiving chemotherapy treatment to take part in the walking intervention 
(Backman et al., 2014). However, this was considered to be a low-intensity activity and no 
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significant differences were seen between groups in HRQoL in individuals with colorectal 
cancer (Backman et al., 2014). To improve outcomes, researchers recommended higher 
intensity exercise, more objective assessment measures, and a larger sample size (Backman 
et al., 2014). 
 While a definite link between exercise levels and the risk of colorectal cancer has 
been established, no scientifically based exercise guidelines have been created specifically 
for individuals with colorectal cancer. More research is required to determine the most 
optimal exercise prescription for individuals during treatment or after treatment for 
colorectal cancer. Developing the most beneficial exercise is a difficult task since this also 
depends on one’s exercise capacity, perception, motivation, and needs (Halle & 
Schoenberg, 2009). Halle and Schoenberg (2009) suggest that individuals with colorectal 
cancer begin with low intensity exercise and gradually increase training over time. 
Exercising three to five times per week for 30-minutes at a time is recommended, ensuring 
that strength training is spaced out by two days to prevent exhaustion (Halle & Schoenberg, 
2009).  
 More recently an RCT by J. H. Park et al. (2015) examined whether oncologists’ 
exercise recommendations of at least 150 minutes of moderate aerobic exercise and twice 
a week strengthening exercises for individuals with breast and colorectal cancer survivors 
(n=162) were more effective with or without the use of motivational tools including an 
exercise DVD, pedometer, exercise diary, and exercise education session. It was 
determined that participants who received the oncologists’ exercise recommendations with 
the motivation tools had significantly increased the amount they participated in exercise 
compared to the control group who did not receive any exercise recommendations or 
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motivation tools (J. H. Park et al., 2015). Also, the oncologists’ exercise recommendations 
alone were not enough to significantly increase the amount of exercise individuals 
participated in and therefore oncologists’ exercise recommendations should be provided 
with tools to help encourage and facilitate exercise participation (J. H. Park et al., 2015). 
 In conclusion, exercise has been shown to reduce the risk of developing colon 
cancer, yet evidence remains inconclusive as to whether exercise has a similar effect on 
rectal cancer. Research has demonstrated that exercise interventions are feasible for 
individuals with colon cancer who are undergoing chemotherapy treatment. More research 
is needed to determine the most beneficial exercise prescription (i.e. type, intensity, 
frequency, and duration) for this population. Also, it has been determined that motivational 
tools (e.g. pedometers, exercise diaries, and educational sessions) are necessary along with 
oncologists’ recommendations to assist individuals with colorectal cancer in increasing 
their levels of exercise participation. 
2.8.4 Exercise and Endometrial Cancer 
Currently, there is limited research examining the effects of exercise on individuals 
with endometrial cancer. The majority of endometrial cancer survivors do not meet current 
exercise recommendations, and many are overweight or obese and have been diagnosed 
with other comorbidities (Smits, Lopes, Das, Bekkers, & Galaal, 2014; von Gruenigen et 
al., 2011). Consequently, this population should be provided with further education about 
the risk of continuing to lead an unhealthy lifestyle and opportunities should be created for 
this group to take part in healthy lifestyle programs including exercise and nutritional 
counselling (von Gruenigen et al., 2011). 
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A systematic review by Smits et al. (2015) (n= 413 participants, 3 RCTs, 1 
randomised parallel intervention trial, 1 controlled trial, 3 single-arm intervention trials) 
concluded that the HRQoL of endometrial and ovarian cancer survivors could be improved 
by lifestyle interventions, such as exercise or nutritional counselling interventions. There 
was only one RCT in the review that examined the feasibility and effect of a physical 
activity intervention on gynaecological cancer survivors (total: n=33; ovarian: n=12; 
endometrial: n=11; uterine n=4; cervical: n=4; mixed gynaecological tumour: n=2) during 
and post treatment (Donnelly et al., 2011). The intervention group (n=16) in the trial 
participated in a 12-week, home-based, moderate intensity exercise behaviour change 
intervention that aimed to follow exercise guidelines of 30 minutes of exercise on at least 
five days of the week (Donnelly et al., 2011). Exercise involved walking and a strength 
training program (Donnelly et al., 2011). At the beginning and at the end of the 12-weeks 
participants met with a physiotherapist and in-between this time weekly phone calls were 
made to track participants’ progress (Donnelly et al., 2011). Standard care was delivered 
to the control group (n=17) with no advice on exercise being provided (Donnelly et al., 
2011). Researchers reported that fatigue as measured by the Multi-Dimensional Fatigue 
Symptom Inventory – Short Form (MDFSI-SF) was significantly decreased in the 
intervention group compared to the control group at the 12-week and six month 
assessments (12-week: mean difference: -11.06, 95% confidence interval (CI): -21.89 to -
0.23, p=0.046; 6 month: mean difference: -19.48, 95% CI: -19.67 to -19.15, p = 0.01) 
(Donnelly et al., 2011). Additionally, a significant difference between groups in the sleep 
dysfunction (measured by the Pittsburgh Sleep Quality Index) was reported at 12-weeks, 
and was maintained at follow up, six weeks later (Donnelly et al., 2011). Other secondary 
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outcome measures (including HRQoL, depression, body composition, physical 
functioning, and self-reported physical activity) did not show any significant differences 
(Donnelly et al., 2011). Overall, researchers found that facilitating an exercise behaviour 
change intervention for gynaecological cancer survivors was feasible since initial 
appointments and phone calls resulted in excellent adherence (Donnelly et al., 2011).  
In summary, while exercise and nutritional counselling is thought to improve the 
HRQoL and reduce symptoms experienced by individuals with endometrial cancer, 
evidence at this time remains limited. More rigorous trials including women with a wide 
range of body mass index (BMI) and physical activity levels are needed (Smits et al., 2015).  
Researchers should aim to investigate the optimal mode, intensity, frequency, and duration 
of exercise protocols for individuals with endometrial cancer and the long-term effects and 
sustainability of exercise needs to be considered (Smits et al., 2015). 
2.9 Nordic Pole Walking 
2.9.1 Walking and Cancer 
 Studies examining the exercise preferences of individuals diagnosed with various 
types of cancer indicate that walking is overwhelmingly the most preferred type of exercise 
(Blaney, Lowe-Strong, Rankin-Watt, Campbell, & Gracey, 2013; L. W. Jones & Courneya, 
2002). In Taiwanese patients with lung cancer, walking was identified as the most preferred 
type of exercise because it is flexible and can be performed alone (Lin, Lai, Lu, Lai, & Lin, 
2013). Exercise preferences are important to consider in research and clinical practice for 
the cancer population since they may result in greater recruitment and adherence rates in 




 Moderate-intensity walking programs have been studied in various cancer 
populations. An RCT by Nyrop et al. (2017) examined the effects of a home-based walking 
program (n=31) on women diagnosed with breast cancer who were experiencing moderate 
to severe aromatase inhibitor-associated arthralgia (AIAA) (including symptoms of joint 
pain, stiffness, and achiness) compared to a control group (n=31) who received the usual 
care (Nyrop et al., 2017). The walking intervention was six-weeks in length and 
participants were asked to walk at a safe, comfortable, and sustainable pace for 150 minutes 
per week (Nyrop et al., 2017). Immediately following the six-weeks, participants in the 
intervention group experienced a significant increase in their walking minutes per week 
(walking group: +76.22 minutes/week (p<0.01); control: +10.52 minutes/week), decrease 
in stiffness, less difficulty with activities of daily living, and less perceived helplessness in 
handling joint symptoms (Nyrop et al., 2017). At the six-month follow up, the improvement 
seen in joint stiffness and daily activities in the walking group was maintained; however, 
the walking minutes per week had decreased significantly (Nyrop et al., 2017). This 
demonstrates that a home-based walking program assisted women with breast cancer in 
managing AIAA. 
 Another RCT examined the effects of a 12-week moderate-intensity, home-based, 
walking program on individuals with lung cancer (n=116) (Chen, Tsai, Wu, Lin, & Lin, 
2015). Participants that were randomly assigned to the walking group (n=58) walked for 
40 minutes per day, three days per week, and received weekly exercise counselling (Chen 
et al., 2015). Participants in the control group (n=58) received the usual care (Chen et al., 
2015). It was determined that individuals in the walking group had a significant 
improvement in their anxiety levels and depression compared to the control group (Chen 
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et al., 2015). Researchers concluded that walking is an effective method for lung cancer 
patients to deal with anxiety and depression and should be encouraged as part of a 
rehabilitation program (Chen et al., 2015). Other studies on individuals diagnosed with 
colorectal and breast cancer support these results (Courneya et al., 2003; Mock et al., 1997). 
 Overall walking as a form of exercise is preferred by cancer patients and moderate-
intensity, home-based walking programs have been found to reduce anxiety, depression, 
and the severity of cancer-related symptoms. With this in mind, NPW is considered as a 
potentially more effective exercise intervention for individuals diagnosed with cancer. 
2.9.2 Overall Effects of NPW 
Nordic pole walking is a low-impact form of exercise that involves walking with a 
pair of poles customized to the participant’s height and stride length. As a registered 
kinesiologist working with individuals who have various health considerations, it has been 
my experience that people are not only enthusiastic about learning to NPW, but that their 
adherence to a prescribed NPW program is greater than to a general walking program. 
While walking will improve an individual’s aerobic capacity, walking with the poles 
increases the use of the upper body creating an opportunity to potentially improve upper 
body muscular endurance as well.  
While NPW has become an increasingly popular type of exercise, research on the 
effects of NPW is still evolving. Fritschi et al. (2012a) conducted a systematic review to 
determine the effects of NPW on physical and psychosocial health. Included in the review 
were 10 RCTs and 3 control trials, 10 published since 2010 (Fritschi et al., 2012a). 
Participants in these studies were primarily mid to older aged men and women with varying 
clinical diagnosis, including type 2 diabetes, cardiovascular disease, musculo-skeletal 
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conditions, chronic obstructive pulmonary disease (COPD), Parkinson’s disease, 
fibromyalgia, Sjogren’s syndrome, and breast cancer. On average the studies included 
about 60 participants and the NPW programs were 14.2 weeks long (Fritschi et al., 2012a). 
There were only two studies of nonclinical populations in this review, leaving healthy 
people without diagnosed conditions inadequately represented (Fritschi et al., 2012a). The 
NPW programs consisted of one to five exercise sessions per week, 20 to 70 minutes in 
length (Fritschi et al., 2012a). Most programs required participants to exercise at moderate 
intensity determined by both subjective and objective measures, including RPE, heart rate, 
and accelerometer data (Fritschi et al., 2012a).  
All studies included in the systematic review had at least one positive effect from 
NPW (Fritschi et al., 2012a). Yet comparison between studies was difficult due to the 
variety of study populations, control groups, and outcome measures. Fritschi et al. (2012a) 
concluded that NPW improved functional status, physical activity, HRQoL, and 
cardiorespiratory outcomes. The effects of NPW on pain, anthropometric measures, muscle 
strength and flexibility, gait parameters, and blood glucose levels were inconclusive 
(Fritschi et al., 2012a). Two other reviews that were published earlier also support these 
results (Laukkanen, 2007; Morgulec-Adamowicz, Marszałek, & Jagustyn, 2011).  
2.9.3 NPW and Cancer 
 The research focusing on the effects of NPW in the cancer population is limited. 
Jastrzebski et al. (2015) conducted a RCT (n=20) where NPW was incorporated into the 
pulmonary rehabilitation program for individuals with advanced stage lung cancer (stage 
III or IV) who were undergoing chemotherapy treatment. The aim of the RCT was to 
determine the effects of pulmonary rehabilitation on exercise efficiency, dyspnea, and the 
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HRQoL of these individuals (Jastrzebski et al., 2015). Twelve patients (NSCLC: n=10, 
small-cell lung cancer: n=2) were randomly allocated to an eight-week hospital-based 
rehabilitation program that involved four two-week rehabilitation cycles, each beginning 
with a round of chemotherapy (Jastrzebski et al., 2015). Depending on their results from 
the 6MWT patients were divided into two groups (Jastrzebski et al., 2015). Group A 
(6MWT > 200 meters (m): n=8) participated in 45 minutes of NPW (70% of predicted 
maximal heart rate), 30 minutes of aerobic and respiratory exercises, and 30 minutes of 
resistance training each day, on five days of the week (Jastrzebski et al., 2015). Group B 
(6MWT < 200m: n=4) participated in an individualized program involving exercises for 
the respiratory muscles and peripheral muscles of the upper and lower extremities (cycle 
ergometer) (Jastrzebski et al., 2015). The eight patients (all diagnosed with NSCLC) 
randomized to the control group did not participate in any rehabilitation program during 
the eight-week period (Jastrzebski et al., 2015). Assessments of all participants were to be 
conducted before and after the eight-week period and some participants stayed in the 
program longer, while others finished earlier than expected due to anemia and general 
weakness (Jastrzebski et al., 2015). No statistically significant improvement was found in 
the 6MWT for those who completed the pulmonary rehabilitation program compared to 
the control group (Jastrzebski et al., 2015). Despite this, there was a definite trend towards 
increased distance that these patients were able to walk after the eight-week training period 
(Jastrzebski et al., 2015). The rehabilitation group went from an average (SD) 6MWT 
distance of 527.3m (107.0) to an average 6MWT distance of 563.9m (64.6) at the final 
assessment (Jastrzebski et al., 2015). In comparison, the control group walked on average 
502.8m (105.0) at the initial 6MWT and 509.4m (134.3) at the final 6MWT (Jastrzebski et 
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al., 2015). In the rehabilitation group, there was a significant increase in forced expired 
volume in one second (66.9 (13.2) versus 78.4 (17.7) of percent predicted; p = 0.016), less 
dyspnea, and a tendency towards improvement in HRQoL (as measured by the 36-item 
short form health survey (SF-36)) compared to the control group (Jastrzebski et al., 2015). 
Pulmonary rehabilitation using NPW was found to be feasible in patients with advanced 
lung cancer during chemotherapy (Jastrzebski et al., 2015). While the small sample size of 
this study made it difficult to determine if significant changes occurred, researchers 
acknowledge the practical implications of the study and suggested that NPW is an 
economical form of exercise that participants can continue independently at home 
(Jastrzebski et al., 2015). 
Most of the research on NPW and individuals with cancer has focused on the breast 
cancer population. Sprod et al. (2005) conducted an eight-week RCT (n=12) to determine 
if NPW would improve shoulder ROM and upper body muscular endurance in female 
breast cancer survivors. Both the NPW group (n=6) and the control group (n=6) met with 
an exercise specialist twice a week to do 20 minutes of walking and a resistance training 
program for eight weeks (Sprod et al., 2005). During the 20 minutes of aerobic activity, 
the NPW group walked with poles while the control group walked without (Sprod et al., 
2005). At the beginning and at the end of the eight-week training period the range of motion 
(including right and left shoulder flexion, extension, and abduction) and muscular 
endurance (including repetitions possible before volitional muscular fatigue doing bench 
press, shoulder press, and latissimus dorsi (lat) pull down) were measured in both groups 
(Sprod et al., 2005). More than 18 months had elapsed since participants had undergone 
treatment and therefore little impairment was found in the shoulder range of motion of 
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either group (Sprod et al., 2005). However, results did show significant improvements in 
the bench press and lat pull down muscular endurance tests in the NPW group compared 
to the control group (Table 1) suggesting that walking with poles helped to improve 
muscular endurance of the upper body (Sprod et al., 2005). 
Table 1. Comparison of Differences in Muscular Endurance between the NPW Group and 
Control Group 
Muscular Endurance Measure NPW Group Control Group 
Bench Press (repetitions) 6.83* -0.8 
Shoulder Press (repetitions) 1.17 -0.4 
Lat Pull Down (repetitions) 13.00* 5.2 
*differs significantly from pretest values (p<0.05)  
Note: Data from The effects of Walking Poles on Shoulder Function in Breast Cancer 
Survivors by Sprod et al. (2005). 
 
 Malicka et al. (2011) also conducted an eight-week RCT examining the effects of 
NPW on the upper body strength and lymphedema in 38 women (average age of 62.8 years) 
who had been treated for breast cancer. The control group (n=15) did no exercise while the 
NPW group (n=23) participated in two 60-minute NPW classes per week (Malicka et al., 
2011). The average upper body pushing muscle strength for the NPW group was only 
significantly higher for the left upper extremity (Malicka et al., 2011). There was no change 
in muscle strength for the pulling motion of the upper extremities (Malicka et al., 2011). 
No occurrence of lymphedema was reported and so NPW was considered a safe form of 
rehabilitation for patients with breast cancer (Malicka et al., 2011). 
 More recently, two feasibility studies exploring the effects of NPW on individuals 
with breast cancer were completed (Fields et al., 2016; Fischer et al., 2015). Fischer et al. 
(2015) aimed to determine the feasibility of a NPW program to help individuals who had 
finished treatment for breast cancer to improve their well-being and shoulder function. Of 
the 28 women who started the NPW intervention, 23 women completed the 10-week 
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program (Fischer et al., 2015). Two women dropped out because of the progress of their 
breast cancer during the program and three other women dropped out due to medical 
reasons unrelated to breast cancer (Fischer et al., 2015). The program involved 10-weekly 
hour long training sessions with the initial six sessions focusing on walking technique and 
the last four sessions focusing on improving endurance and muscle strength (Fischer et al., 
2015). Subjective well-being (measured using the SF-36) and individual’s perceptions of 
shoulder mobility were assessed at the start of the program, at the end of the program, and 
then again six months later (Fischer et al., 2015). Shoulder range of motion was also 
measured at the beginning and at the end of the program (Fischer et al., 2015). Focus groups 
were held six months after the program so that researchers could gain insight into the 
participants’ experiences and the perceived benefits and drawbacks of the intervention 
(Fischer et al., 2015). At three and six months, subjective wellbeing showed significant 
improvement in vitality compared to baseline (Fischer et al., 2015). During the focus 
groups, researchers learned that participants greatly valued the social support that they 
received from others taking part in the study (Fischer et al., 2015). This social support 
continued after the end of the program as participants could relate to similar physical and 
psychosocial consequences from cancer and treatment (Fischer et al., 2015). Fischer et al. 
(2015) concluded that NPW is a feasible and enjoyable activity for breast cancer survivors. 
The exploratory nature of this study meant there were several limitations, including no 
control group for comparison and a small sample size (Fischer et al., 2015).  
 Fields et al. (2016) conducted a feasibility study (n=40) using a randomized control 
design to examine the effects of a NPW program for women with breast cancer who had 
AIAA. Women who were randomized to the NPW group (n=20) participated in one 
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supervised NPW session per week for six weeks, followed by another six weeks of NPW 
independently four times a week for 30-minutes (Fields et al., 2016). The control group 
(n=20) received enhanced usual care where they were contacted twice a week to check if 
they were experiencing any new pain, injury, or lymphedema (Fields et al., 2016). 
Researchers collected data on feasibility outcomes, including recruitment, attrition and 
adherence rates, safety, suitability of methods, and physical activity levels of participants 
(Fields et al., 2016). On average participants were 63 years old, 36-months post diagnosis, 
had been on endocrine therapy for 27 months and had been experiencing arthralgia for 22 
months (Fields et al., 2016). All of the study participants had been treated for breast cancer 
surgically, 75% were also treated with radiation, and 50% had chemotherapy (Fields et al., 
2016). There was a 10% attrition in the NPW group with two participants dropping out of 
the study before the intervention started due to other commitments and one due to sudden 
bereavement (Fields et al., 2016). Two other participants dropped out after the first six-
weeks of NPW because of longstanding musculoskeletal problems unrelated to AIAA 
(Fields et al., 2016). No one in the control group dropped out of the study (Fields et al., 
2016). There was a high level of adherence (90%) for the supervised weekly NPW sessions 
and during the unsupervised NPW sessions (one to two walks per week was achieved by 
68%-85%) (Fields et al., 2016). Over the twelve-week period, 39% of NPW participants 
reported an increase in vigorous physical activity (including NPW), but no participants 
reported a change in walking activity. Comparatively, 15% of control group participants 
reported an increase in their vigorous activity and 45% of the control group reported an 
increase in their walking activity (Fields et al., 2016). In the survey completed at the end 
of the study, all participants indicated that they enjoyed NPW and 81% confirmed that they 
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intended to continue to exercise three to four times per week (Fields et al., 2016).  This 
study determined that it is possible to recruit and retain women with AIAA to participate 
in NPW and that NPW is found to carry a low risk of injury and did not make the 
lymphedema experienced by participants worse (Fields et al., 2016). 
Overall, there has been little research done on NPW in individuals with cancer. 
Research has found that for individuals with breast cancer, NPW is a safe form of 
rehabilitation and that it may help to improve the muscular endurance of the upper body 
(Malicka et al., 2011; Sprod et al., 2005). When NPW was incorporated into pulmonary 
rehabilitation for lung cancer patients, a significant increase in forced expired volume in 
one second and a trend towards improved exercise capacity, HRQoL, and less dyspnea 
were shown (Jastrzebski et al., 2015). Feasibility studies on NPW and individuals with 
breast cancer have established that program adherence is generally high, physical activity 
levels of participants are improved, and overall enjoyment is apparent (Fields et al., 2016; 
Fischer et al., 2015). Future research should investigate how NPW impacts the physical 
function and HRQoL of individuals with various types of cancer. Outcome measures that 
are common within the cancer population should be applied when possible to allow 
researchers to compare NPW to other exercise modalities. 
2.9.4 NPW and Quality of Life 
In the literature, quality of life and HRQoL are often used interchangeably, however 
they do have different meanings and therefore it is important to define these two terms. 
Quality of life is a broad term that refers to all aspects of an individual’s life including (but 
not limited to) psychological, economical, biological, and social aspects (hnoble, 2014; 
Karimi & Brazier, 2016). While HRQoL overlaps with quality of life, it is centred on the 
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specifics of how illness and treatment impact one’s quality of life (hnoble, 2014; Karimi & 
Brazier, 2016).  
One study out of four (Breyer et al., 2010) on NPW (Collins et al., 2005; Gram, 
Christensen, Christiansen, & Gram, 2010; Strombeck, Theander, & Jacobsson, 2007) 
showed significant improvement in some HRQoL domains of the Medical Outcomes Study 
36 Item Short-Form Health Survey (SF-36). The SF-36 includes eight domains that can be 
categorized as part of the physical component summary (PCS) score or the mental 
component summary (MCS) score. Both scores range from 0 to 100 and a score greater 
than 50 points represents a better generic HRQoL.  
Breyer et. al (2010) in a RCT, compared a three month NPW program (n=30) to no 
intervention (n=30) in 60 COPD patients. At baseline, 53 patients with COPD had an 
impaired PCS score (<50 points) and 30 patients had an impaired MCS score (<50 points) 
(Breyer et al., 2010). The NPW group significantly increased their PCS scores compared 
to baseline and controls, and these scores continued to be improved after six and nine 
months (Table 2) (Breyer et al., 2010). Controls showed no change in PCS scores after 
three, six, and nine months compared to baseline (Table 2) (Breyer et al., 2010). Both the 
NPW group and the control group did not show any change in MCS scores at any time over 








Table 2 – SF-36 Scores for Individuals with COPD Over Time 
SF-36 
Component 





















































Statistical comparisons within groups: * p<0.01 compared to baseline 
Statistical comparisons between groups (Nordic Walking vs. Control): ‡ p<0.01, § p<0.05 
Note: Reprinted from Nordic Walking Improves Daily Physical Activities in COPD: a 
randomised control trial by Breyer, et al. (2010). 
 
 In summary, more research on the effects of NPW on HRQoL is needed. 
Researchers should consider using the SF-36 questionnaire so that comparisons between 
trials can be made. 
2.10 Gaps in Literature and Future Research 
 There is increasing evidence that exercise is beneficial for individuals who are 
diagnosed with cancer, but more research is needed. Low to moderate intensity exercise is 
safe, and can be effective at improving the HRQoL of individuals with cancer who are 
undergoing treatment or who have completed treatment (Mishra et al., 2012). General 
exercise guidelines for this population have been created (Schmitz et al., 2010; Segal et al., 
2015), although further research should be done to determine the most effective type of 
exercise according to mode, intensity, frequency, duration, and timing. Providing health 
care professionals with this information would assist them in making sure that the exercise 
prescription they provide is appropriate, safe, and effective.  
 In some cancer populations research on exercise is more limited than others. For 
example, as mentioned earlier, lung cancer is the most commonly diagnosed type of cancer 
in Canada (14% of all cancer cases) (Canadian Cancer Society, 2016), yet there remain few 
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RCT’s with high quality research on exercise in this population. Studies investigating the 
effects of exercise on individuals with endometrial cancer is also limited. It is important to 
understand how exercise effects individuals with various cancer diagnoses. What may be 
most beneficial for individuals with one type of cancer may not be for individuals 
diagnosed with another type of cancer. A better understanding of the role exercise can play 
in various cancer diagnosis will allow for more individualized exercise programing. 
Additionally, studying exercise in individuals with certain types of cancer is difficult and 
therefore, effort needs to be made to better understand and overcome the barriers to 
research in these populations. More rigorous methodological studies (i.e. RCTs) examining 
the effects of exercise are needed. Future trials should consider the long-term effects and 
sustainability of exercise. 
 Nordic pole walking has been shown to improve functional status, physical activity 
(including exercise), HRQoL, and cardiorespiratory outcomes of adults with various 
clinical diagnosis (Fritschi et al., 2012a). Current research on NPW in the cancer 
population focuses on the upper body strength and range of motion of breast cancer 
survivors. One study exploring the effects of an eight-week pulmonary rehabilitation 
program involving NPW combined with aerobic and resistance exercises in individuals 
with lung cancer found that patients in the NPW group tended to be able to walk a greater 
distance and have improved HRQoL compared to the control group (Jastrzebski et al., 
2015). This trend towards improved functional exercise capacity and HRQoL warrants 
further investigation in individuals with various types of cancer.  Walking with the poles 
is a low-impact, inexpensive, and practical type of exercise that anyone can participate in. 
The uncomplicated nature of NPW makes it a practical alternative for individuals with 
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cancer to incorporate into their lifestyle. In the future, RCTs with larger sample sizes 
should be conducted. The most appropriate outcome measures for the cancer population 
need to be considered so that comparisons can be made to other exercise protocols that 



























3.1 Study Design 
This was an eight-week multi-centre randomized controlled pilot study to assess 
the feasibility of examining the effects of Nordic pole walking (NPW) on the physical 
function and health-related quality of life (HRQoL) of individuals with non-small cell lung 
cancer (NSCLC), prostate cancer, colorectal cancer, and endometrial cancer. Examining 
feasibility allows researchers to establish optimal study design and operational processes 
(Gardner et al., 2003; Thabane et al., 2010). The intervention group participated in a 
community-based individualized NPW program, while the control group continued their 
usual daily routine.  
3.2 Participants 
3.2.1 Eligibility Criteria 
 
Inclusion criteria were: 1) a primary diagnosis (including a cancer reoccurrence) of 
histologically confirmed stage I-IV NSCLC, prostate cancer*, colorectal cancer*, or 
endometrial cancer* (with any concurrent cancer treatment) (*Note: These types of cancer 
were included later as a result of difficulty recruiting individuals with NSCLC.); 2) over 
the age of 55 years;  3) able to communicate in English; 4) diagnosed or treated for cancer 
within the last three years; 5) approval by the primary treating physician to participate in 
an exercise program; and 6) the capacity to consent as judged by the researchers (e.g., 
cognitive impairment).  Participants were excluded if they had been using Nordic walking 
poles on a regular basis within the last six-months. 
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Ethical approval was obtained from the University of Ontario Institute of 
Technology and both community-based hospitals involved in the study. All participants 
provided written consent to take part in the study prior to their initial assessments. 
3.2.2 Recruitment 
 
 Researchers used several strategies to recruit participants over eight-months 
including: 1) recruiting participants from community-based hospitals; 2) displaying posters 
in various locations; 3) posting information on social media websites; 4) attending cancer 
support group meetings; and 5) promoting snowball referrals from clinician experts and 
participants.  
1) Hospital Recruitment: Recruitment took place at two community-based hospital sites in 
the Greater Toronto Area (GTA) where potential study participants with NSCLC were 
screened and introduced to the study by the primary treating physician and/or the oncology 
nurses during their clinic visits. Potential participants were provided with a study 
information page to read on their own time (Appendix A). At Community Hospital 1, 
interested potential participants were asked to directly contact researchers. At Community 
Hospital 2, interested potential participants provided consent to the nurses to release their 
contact information to the research team. The name and contact information of potential 
participants were then forwarded to the research team who contacted them to obtain 
informed consent. 
2) Posters: Posters informing potential participants about the study were displayed at 
various community-based cancer centres and clinics including Wellspring Cancer Support 
Centres and the Hearth Place Cancer Support Centre as well as at the recreational facilities 
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where the NPW intervention took place (Appendix B). Interested participants were 
provided contact information to inquire further about the study. 
3) Social Media: Social media was used as a recruitment tool to reach out to the lung cancer 
community. Messages and information were intended for clinician experts, professional 
societies, and patient advocacy groups to make them aware of the study. The Twitter 
account for the study was @NPWlungcancer and the Facebook account was 
https://www.facebook.com/NPWlungcancer/?ref=aymt_homepage_panel. 
4) Cancer Support Groups: Researchers spoke directly to individuals with colorectal 
cancer about the study at support group meetings and worked with both the colorectal 
cancer and prostate cancer support group leaders to send out emails with information about 
the study to individuals who attended these support groups. 
5) Snowball Referrals from Clinician Experts and Participants: Clinician experts across 
the country who regularly provided care for individuals with cancer or instructed NPW 
were informed about the study by email. This included: oncology surgeons, 
physiotherapists, kinesiologists, and massage therapists. An article (Cunningham, 2016) 
describing the importance of exercise in the lung cancer population and providing 
information about the study was published in the Ontario Respiratory Care Society 
professional development publication. The purpose of this article was to provide 
knowledge translation and to assist with snowball sampling. To recruit individuals 
diagnosed with NSCLC an information session about NPW and the study was held by 
researchers at a Senior Centre near the Community Hospital 2 during a seniors’ lunch. 
A sample size calculation was not performed prior to conducting the study because 
the primary outcome measure of the study was feasibility. Pilot studies are not designed to 
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determine effect size, but rather to help test and refine the study design (Tappin, 2014). We 
anticipated enrolling 10 participants per group prior to conducting the study. Suggested 
sample sizes for pilot studies are 10% of the sample expected for the larger study or 10 to 
30 participants (Tappin, 2014). The sample sizes of pilot studies are not easy to determine 
because these studies are influenced by many unpredictable factors. It is important to have 
a large enough sample to thoroughly examine the study methodology (Tappin, 2014). 
3.2.3 Randomization 
 
Block randomization (block size of 4) of intervention and control groups was 
computer generated (Sealed Envelope Ltd., 2015) and administered by a person who was 
at arm's length from the study. The person who coordinated the randomization process was 
not involved in the screening process or outcome assessments. Allocation was concealed 
by placing the assignment within aluminum foil, and then in opaque envelopes. Study 
participants opened the allocation envelope after consenting to the study and upon 
completion of the initial assessment. Since this was an exercise intervention, it was not 
possible to blind the intervention from participants and the assessors. 
3.3 Study Procedures 
The flow of study procedures is detailed in Figure 3. During the study, participants 
had a baseline assessment, an eight-week NPW or control period, and then a follow-up 
assessment within two weeks of completing the intervention or control period. Participants 
who were in the intervention group were given the option to have weekly follow-up phone 
calls or emails for added support and encouragement during the NPW program. When 
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participants completed the NPW program, they were asked to complete the program 























Figure 3. A detailed layout of the randomized controlled pilot study procedures. 
Intervention Group 
 
• Nordic Pole Walking (8 weeks) 
• personalized program 
• supervised group sessions 
-­‐‑ 1x per week 
-­‐‑ 20 – 30 minutes of walking 
-­‐‑ cool down / discussion 
• unsupervised individual sessions  
- between 1 to 3x per week 
- optional phone calls / emails 
for support 





• usual daily routine (8 weeks) 
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3.3.1 Feasibility Analysis 
 
The framework proposed by Thabane et al. (2010) was used to assess the study’s 
design, operation, and feasibility.  The framework employs four criteria: “Process” 
(assesses the feasibility of the processes that are critical to the success of the study); 
“Resources” (assesses time and resource problems that can occur during the study); 
“Management” (assesses potential human and data management problems); and 
“Scientific” (assesses treatment safety, dose response, effect, and variance of the effect). 
Within each category the following was examined, considered, and monitored:  
1)   recruitment, consent, and randomization procedures;  
2)   sample size required for a full study;  
3)   inclusion/exclusion process;  
4)   appropriateness of assessment tools used in the study;  
5)   appropriate timing of data collection;  
6)   suitability of data collection materials;  
7)   operational processes; and  
8)   protocols for NPW exercise prescription.  
Table 3 describes in detail each feasibility objective, measure, and respective outcomes. 








Table 3. Feasibility Objectives, Measures and Outcomes 
Objective   Measures Outcomes 
Process 
Assesses the feasibility of the 
processes that are critical to the 
success of the study. 
1.   Recruitment rate 
2.   Are the inclusion and 
exclusion criteria 
appropriate (too limited or 
too broad)?  
3.   Were there any 
complications with 
recruitment? 
4.   Which stage (I-IV) of cancer 
patients was best to include 
in this study? 
5.   Which cancer treatments 
(surgery, chemotherapy, 
radiation, and other drug 
therapy treatments) are most 
appropriate for study 
patients to be receiving? 
6.    How appropriate were 
recruitment procedures? 
1.   Recruitment rate tracked on 
call tracking sheet 
(Appendix D) 
2.   Review of call tracking sheet 
(Appendix D) to see who 
was considered for study 
(limited – there were a 
significant # of people 
considered, but not enrolled; 
broad - everyone considered 
was enrolled, some of these 
people may have had 
difficulty completing the 
NPW program) 
3.   Field notes – documented 
challenges during 
recruitment  
4.   Adherence rate, reasons for 
not enrolling in or 
withdrawing from the study  
5.   Adherence rate, reasons for 
not enrolling in or 
withdrawing from the study  
6.   Recruitment rate & field 
notes - Reflection of overall 
recruitment process, could 
any changes be made to 
improve process? 
Resources 
Assesses time and resource 























7.   How did the recruitment 
procedure impact the 
hospital staff? 
8.   Enrolment, adherence, and 
completion rates 
9.   What are the reasons for 
enrolling or not enrolling in 
the study? 
10.   What are the reasons for 
non-adherence to the NPW 
program? 
11.   What are the reasons for loss 
to follow up? 
12.   Did weekly follow up 
contact (phone or email) 
have an effect on adherence?  
13.   How long did it take to 
complete the assessments? 
14.   Were there too few or too 
many outcome measures? 
15.   Was the testing equipment 
readily available when 
needed? 
7.   Field notes – any 
documented comments made 
by hospital staff or 
complications with 
procedures at hospital 
8.   Attendance records, exercise 
logs (Appendix E) 
9.   Call tracking sheet 
(Appendix D) documents 
reasons for participation or 
nonparticipation  
10.   Exercise log (Appendix E) – 
patient documents reasons 
for not adhering to required 
NPW sessions  
11.   Attendance records – effort 
made to find out reasons for 
loss to follow up 
12.   Patient follow-up survey 
(Appendix C) – ask patients 
if they felt follow up contact 
was helpful 
13.   Recorded time of assessment 






16.   How long did it take to make 
regular follow up contact via 
phone or email? 
17.   How long were the NPW 
classes? 
18.   How many participants 
could participate in one 
NPW class? 
19.   Costs for the following: 
facility rental, Nordic Poles, 
assessment equipment, 
administrative tasks 
(printing), phone bills, 
miscellaneous 
14.   Field notes - did patients 
comment on timing of 
assessment? - reflection of 
recorded time  
15.   Field notes – comments on 
availability of assessment 
equipment 
16.   Follow up contact tracking 
sheet (Appendix F) - 
recorded time of follow up 
17.   Field notes – recorded time 
of each class – includes set 
up and take down 
18.   Attendance sheet & field 
notes – documentation of 
number of patients per class, 
comments regarding class 
procedures that indicate 
impact of number of patients 
per class 
19.   Expense tracking sheet 
(Appendix G) 
Management 
Assesses potential human and 
































20.   Did the patients understand 
how to complete the tasks 
and questionnaires? 
21.   Were the patients able to 
complete the assessment 
tasks and questionnaires? 
22.   Did the recreational centres 
do what they committed to 
doing? 
23.   Was the partnership with the 
Nordic pole company 
effective? 
24.   Was there appropriate space 
to perform the assessment 
and NPW program? 
25.   Were the research assistants 
able to assist with the patient 
assessments and facilitate 
the NPW program? 
26.   What other challenges did 
the research team have? 
27.   Did participants find the 
exercise journal helpful? 
28.   What were the challenges 
that patients experienced 
when NPW independently? 
29.   Were the exercise tracking 
sheets appropriate? 
30.   Was there enough room on 
the data collection sheets? 
20.   Field notes – reflection on 
communication of 
assessment tasks 
21.   Assessment tracking sheets 
(Appendix H & I) & field 
notes – any challenges with 
completing assessment tasks 
22.   Field notes – review of 
relationship with recreation 
centres – successes or 
challenges 
23.   Field notes – review of 
relationship with Nordic pole 
company – successes or 
challenges 
24.   Field notes – any difficulties 
that were noted with space 
allotted for assessment (area, 
accessibility, noise level etc.) 
25.   Field notes – discussion with 
research assistants about 
their experience & 
observations made regarding 
ability to assist with study 
process 
26.   Field notes – discussion with 
research assistants about 
challenges they faced 
27.   Patient follow up survey 
(Appendix C) & field notes – 
any discussion that was 
documented on helping 
participants adhere to and 






28.   Patient follow up survey 
(Appendix C) & field notes – 
any discussion that was 
documented on challenges 
participants experienced 
when NPW independently 
29.   Exercise logs (Appendix E) 
& patient follow up survey 
(Appendix C) – were 
exercise logs filled out 
correctly 
30.   Were data collection sheets 
filled out correctly with 
sufficient room? 
Scientific 
Assesses treatment safety, dose 
response, effect, and variance 
of the effect. 
31.   Were there any outcome 
measures that should have 
been assessed that were not? 
32.   Did patients find the NPW 
program too easy or 
difficult? 
33.   Was there a training effect? 
If so, how long did it take 
for patients to understand 
how to walk with the poles? 
34.   How many participants 
purchased Nordic poles upon 
completing the study? 
35.   Was NPW safe? 
31.   Field notes – were any 
changes noticed that were 
not considered? 
32.   Patient follow up survey 
(Appendix C), exercise logs 
(Appendix E), field notes – 
look at adherence to 
program, observations made 
on ability to NPW during 
class 
33.   Field notes – observations 
made of ability to learn 
NPW during first few weeks 
of study 
34.   Patient tracking sheet 
(Appendix F) – ask 
participants if they would 
like to purchase Nordic poles 
35.   Field notes noting any 
adverse effects 
 
 Following the Thabane et al. (2010) framework for conducting a pilot study, there 
are four possible outcomes: 1) stop – the study is not feasible; 2) continue, but modify the 
protocol – the study is feasible with modifications; 3) continue without modifications, but 
monitor closely – the study is feasible with close monitoring; and 4) continue without 
modifications – the study is feasible as is. Ideally, the specific acceptable outcomes for 
each of the four criteria should have been identified a priori to determine if the study was 
feasible or not. Instead, the outcome of the pilot study was determined by analyzing the 
overall process, resources, management, and scientific outcomes described in Table 3. 
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 Upon study completion, researchers received additional feedback on the main 
operational processes from research assistants and nurses. In addition to using this 
framework, participants who completed the NPW program were asked to reflect on their 
experience and provide feedback by completing a program evaluation survey (Appendix 
C). The survey included close-ended questions where participants were asked to rate 
whether they agreed or disagreed with statements about the NPW program and their 
experience participating on a scale of one (agreed with the statement) to five (disagreed 
with the statement).  
 The statements asked participants who completed the NPW program (including 
those in the control group who completed the program after) to consider the following:  
•   how easy or difficult it was to participate,  
•   whether motivation, fatigue, or anxiety made participating in the program 
challenging,  
•   how beneficial the program was to them,  
•   whether they would recommend the program to others with cancer,  
•   how well they were able to master the technique of NPW and follow the prescribed 
program,  
•   how well organized the program was,  
•   how helpful the instructors were, and  
•   whether they would be continuing to NPW on their own after the study.  
The survey concluded with open-ended questions where participants were asked to provide 
feedback on what they liked about participating in the NPW program, what challenges they 
experienced while participating in the NPW program, and how they would improve the 
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NPW program in the future. Additional space was provided for any other comments or 
feedback from participants. 
3.3.2 NPW Outcome Measures 
 
The NPW assessment measures include: 1) demographic information, health 
history, and physical attributes; 2) lower body physical function; 3) upper body physical 
function; and 4) HRQoL. 
3.3.2.1 Demographic Information, Health History, and Physical Attributes: 
During the baseline assessment, each participant provided demographic 
information as well as details about their cancer diagnosis and treatment, side effects, 
general health history, and smoking status. Participation in regular physical activity and 
exercise is closely related to population mental and physical health (Hills, Street, & Byrne, 
2015). As previously mentioned physical activity refers to “any bodily movement produced 
by skeletal muscles that results in energy expenditure” (Caspersen et al., 1985, p. 126). 
Exercise is a type of physical activity that is “planned, structured, repetitive, and purposive 
in the sense that improvement or maintenance of one or more components of physical 
fitness is an objective” (Caspersen et al., 1985, p. 128). Improving physical activity levels 
is important in the prevention and management of chronic diseases (Hills et al., 2015). To 
measure physical activity level (within the last week), participants completed the short 
form self-administered International Physical Activity Questionnaire (IPAQ) (IPAQ 
Group, 2004) at baseline and post intervention. The short form IPAQ is used to collect 
comparable data on health-related physical activity. Questions are asked about walking, 
moderate-intensity activities, vigorous-intensity activities, and sitting during the following 
four domains: a) leisure time physical activity; b) domestic and gardening activities; c) 
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work-related physical activity; and d) transport-related physical activity. Researchers were 
available to answer any questions from participants about the IPAQ as they completed it. 
Researchers also documented and described any planned exercise that participants were 
taking part in at the time of the baseline and final assessments. Resting heart rate and 
oxygen saturation (Nellcore N-20, probe Durasensor DS-100A) levels were also recorded 
as part of the baseline and final assessments. 
Participants’ height, weight, and circumference measurements (bicep, chest, waist, 
hips, and thigh) were taken at both the baseline and final assessment. Anthropometric 
measures provide information about the dimensions of bone, muscle, and adipose tissue of 
participants in the study. Individuals with increased amounts of adipose tissue are at risk 
for many chronic diseases including hypertension, diabetes, cardiovascular disease, 
arthritis, and cancer (Canadian Society of Exercise Physiology, 2013; Health Canada, 
2003). In Canada, body mass index (BMI) (BMI = weight (kilograms) / height (meters)2) 
and waist circumference are used to determine the risk of developing health complications 
due to being overweight or underweight (Canadian Society of Exercise Physiology, 2013). 
A BMI of 18.5 to 24.9 is considered normal with the least risk for health complications 
(Canadian Society of Exercise Physiology, 2013). In comparison, an individual with a BMI 
of 25.0 to 29.9 is considered overweight and an individual with a BMI of 30 plus is 
considered obese (Canadian Society of Exercise Physiology, 2013). A higher BMI is 
associated with increased risk for health complications (Canadian Society of Exercise 
Physiology, 2013).  The Canadian Guidelines indicate that for a person 65 years of age and 
older the normal range of BMI may be slightly higher (Health Canada, 2003). A waist 
circumference of 90 centimeters or more in men and 80 centimeters or more in women is 
66 
 
associated with increased risk for diabetes, coronary heart disease, and hypertension 
(Canadian Society of Exercise Physiology, 2013).  
 For all anthropometric measurements participants were asked to remove footwear 
and wear a minimal amount of clothing. Height measurements were taken against the wall, 
with feet close together. Participants were weighed on an electric scale (Weight Watchers 
Glass Body Analysis Scale, Conair Consumer Products Inc., Woodbridge, Ontario, 
Canada). Waist circumference was measured at the highest point of the iliac crest 
(Canadian Society of Exercise Physiology, 2013). For all other circumference 
measurements, there are no international standards, but researchers used the same method 
consistently throughout the study. Bicep circumference was measured with the 
participants’ arms at their side and the measurement was taken at the midway point 
between the acromion process and the olecranon process (Wood, 2001a). Chest 
circumference was measured at the fullest part of the participant’s bust, under the axilla 
with arms relaxed at their sides (Wood, 2001b). Hip circumference was measured around 
the maximum posterior extension of the buttocks (Wood, 2001c). Thigh circumference was 
measured with the participant’s weight evenly distributed between both feet and the 
measurement was taken midway between the inguinal crease and the patella (Wood, 
2001d).  
3.3.2.2 Lower Body Physical Function: 
Lower body physical function was measured during the baseline and final 
assessment using the six-minute walk test (6MWT) (American Thoracic Society, 2002) 
and the 30-second (30-s) chair stand test (C. J. Jones, Rikli, & Beam, 1999). The 6MWT 
has been recognized as a valid measure of submaximal functional capacity in those with 
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pulmonary disease and cancer (American Thoracic Society, 2002; Schmidt, Vogt, Thiel, 
Jager, & Banzer, 2013). This self-paced test assesses aerobic fitness by measuring the 
distance that an individual can walk over a 25 or 30 metre track in six minutes (American 
Thoracic Society, 2002). Granger, Holland, Gordon, and Denehy (2015) estimated the 
minimal clinical important difference (MCID) for deterioration of the 6MWT in lung 
cancer patients to be between 22 meters and 42 meters or a change of 9.5%. Having a 
greater 6MWT distance was correlated with better function, increased physical activity, 
and decreased dyspnea (Granger et al., 2015).  
The 30-s chair stand test is a valid indication of lower body strength in the older 
adult population (C. J. Jones et al., 1999). The test requires participants to complete as 
many sit to stands as possible in 30 seconds (C. J. Jones et al., 1999). The MCID for the 
30-s chair stand test in the cancer population has not been determined; however, there are 
MCID values for individuals with hip osteoarthritis (MCID within patient: 2.6 repetitions; 
MCID between patient: 2.1, p=0.06) (Wright, Cook, Baxter, Dockerty, & Abbott, 2011). 
3.3.2.3 Upper Body Physical Function: 
 
Upper body physical function was measured during the baseline and final 
assessments with the Unsupported Upper Limb Exercise Test (UULEX) (Janaudis-
Ferreira, Hill, Goldstein, Wadell, & Brooks, 2013; Takahashi, Jenkins, Strauss, Watson, & 
Lake, 2003) and the hand grip strength test (Kilgour et al., 2013; Navigante et al., 2013). 
The UULEX is a valid incremental test that has been used to measure peak unsupported 
arm exercise capacity in the chronic lung disease population (Janaudis-Ferreira et al., 2013; 
Takahashi et al., 2003). It has not currently been used in the cancer population. The test 
requires the seated participant to lift a bar (0.2 kg) through eight levels at a constant cadence 
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of 30 beats per minute as directed by a metronome. The test begins with a two-minute 
warm up where the participant moves the bar extending their arms from neutral to the first 
level. After the warm up the participant lifts the bar to the next higher level for one minute. 
This progression continues every minute until the maximum height is reached. At this time, 
the weight of the bar is increased by 0.5 kg every minute to a maximum weight of 2.0 kg. 
The test continues until the participant experiences fatigue and decides to stop. Normative 
values for the UULEX in the healthy Canadian population were established by Lima et al. 
(2017) and compared to the study population.  
Handgrip strength is correlated with survival, weight loss, sarcopenia, and HRQoL 
characteristics in advanced cancer patients (Kilgour et al., 2013; Navigante et al., 2013). 
Individuals were seated holding the dynamometer (Jamar® Hydraulic Hand Dynanometer, 
Patterson Medical Supply Inc, Mississauga, Ontario, Canada) in one hand with their 
shoulder adducted, elbow flexed 90 degrees, and their forearm in neutral (Rehabilitation 
Measures Database, 2014). Three successive trials for both hands were recorded and the 
maximum grip strength was determined by averaging these three trials for each hand 
(Rehabilitation Measures Database, 2014). The MCID for grip strength in the cancer 
population has not been established, however the MCID for grip strength has been 
identified for individuals who have had a stroke (MCID: 5.0 kg and 6.2 kg for affected 
dominant and non-dominant sides) (Lang, Edwards, Birkenmeier, & Dromerick, 2008). 
3.3.2.4 Health-Related Quality of Life: 
 
The HRQoL of participants was assessed using the 36-Item Short Form Health (SF-
36) questionnaire (Ware & Sherbourne, 1992) during the baseline and final assessments. 
The SF-36 has been validated and used extensively as a measure of HRQoL (Ware & 
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Sherbourne, 1992). It assesses eight health concepts: 1) limitations in physical activities 
because of health problems; 2) limitations in social activities because of physical or 
emotional problems; 3) limitations in usual role activities because of physical health 
problems; 4) bodily pain; 5) general mental health (psychological distress and well-being); 
6) limitations in usual role activities because of emotional problems; 7) vitality (energy and 
fatigue); and 8) general health perceptions. The SF-36 has been used in other studies to 
examine HRQoL in the cancer population (Brocki et al., 2014; Cormie, Newton, Spry, et 
al., 2013; Edvardsen et al., 2014; Galvao et al., 2014; Lemonnier et al., 2014; S. W. Park 
et al., 2012; Stigt et al., 2013; von Gruenigen et al., 2012). Canadian normative data for the 
SF-36 was established by Hopman et al. (2000) and compared with the study population.  
Participants diagnosed with NSCLC also completed the Functional Assessment of 
Cancer Therapy – Lung (FACT-L) questionnaire (Cella et al., 1995) during the baseline 
and final assessment. The FACT-L is a valid and reliable measure of HRQoL (Cella et al., 
1995). The questionnaire includes four general and one lung cancer symptom-specific 
domain. The general domains (27 questions) include: physical well-being (PWB), 
social/family well-being (SWB), emotional well-being (EWB), and functional well-being 
(FWB). The lung cancer symptom specific (LCS) domain (7 questions) evaluates 
symptoms that are commonly experienced by lung cancer patients (i.e. shortness of breath, 
weight loss, and chest tightness). Domain scores are then combined to calculate the Total 
Outcome Index (TOI) (TOI = PWB + FWB + LCS), Functional Assessment of Cancer 
Therapy – General (FACT-G) score (FACT G = PWB + SWB + EWB + FWB), and FACT-





The intervention group participated in an eight-week community-based 
individualized NPW program. An eight-week NPW training period was selected because 
this was the average training time used in other NPW studies, demonstrating that 
individuals could experience changes in this amount of time (Fritschi et al., 2012a). 
Participants were instructed on walking with the poles immediately after their initial 
assessment and were asked to practice using the poles for one-week prior to starting the 
program to allow them time to improve their NPW technique. To assist with program 
adherence, the NPW prescription was individualized to meet needs of each participant as 
recommended by Bourke et al. (2013). The IPAQ was used as an indicator of each 
participant’s cardiorespiratory fitness since it has been correlated with maximal oxygen 
uptake (VO2max) (Schembre & Riebe, 2011). Based on each participant’s IPAQ score and 
their observed ability level during the instruction, participants were categorized to a NPW 
prescription group. These categories were used as a starting point with adjustments made 
to the NPW prescription when needed. The NPW prescription groups were categorized as 
follows:  
1)   Highly Active Group: Participants assigned to this NPW exercise 
prescription were categorized as having a ‘high’ total physical activity 
IPAQ score. As defined by the IPAQ these participants performed 
vigorous-intensity physical activity on at least three days achieving a 
minimum of at least 1500 metabolic equivalents (METS)-minutes/week, 
or on seven or more days they completed any combination of walking, 
moderate-intensity, or vigorous-intensity activities achieving a 
minimum of at least 3000 METS-minute/week (IPAQ Group, 2004). 
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This exercise prescription began with 30 minutes of walking and 
progressed at a relatively fast pace to 60 minutes of NPW on the eighth 
week of the program (Appendix J).  
2)   Minimally Active Group: Participants assigned to this NPW exercise 
prescription were categorized being ‘minimally active’ according to 
their total physical activity IPAQ score. These participants had: i) three 
or more days of vigorous physical activity of at least 20 minutes per day, 
ii) five or more days of moderate-intensity physical activity or walking 
of at least 30 minutes per day, or iii) five or more days of any 
combination of walking, moderate-intensity, or vigorous intensity 
physical activities achieving a minimum of at least 600 METS-
minutes/week (IPAQ Group, 2004). This exercise prescription began 
with 30 minutes of walking and gradually progressed to 35 minutes, 40 
minutes and finally 45 minutes of walking (Appendix K).  
3)   Inactive Group: Participants assigned to this NPW exercise prescription 
were categorized as being “inactive” according to their total physical 
activity IPAQ score. This means that these participants either reported 
no physical activity at all or some physical activity, but not enough to 
meet the minimally or highly physically active criteria (IPAQ Group, 
2004). It was not uncommon for this group of participants to require 
breaks when walking, especially as the amount of time that they were 
walking increased. This exercise prescription began with 20 minutes of 
walking and gradually progressed to 25 minutes and finally 30 minutes 
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of walking (Appendix L).  
Participants were instructed to closely monitor themselves using the Borg Rate of 
Perceived Exertion (RPE) scale (six to 20, higher number indicating greater exertion) and 
to maintain exertion to levels that suited their physical capacity (moderate intensity RPE 
between 12 and 15) (Reed & Pipe, 2016). Throughout the study participants were instructed 
to follow their specific individualized NPW prescription. To meet the specific needs of 
each participant, instructors modified the prescribed NPW program as necessary. For 
example, if a participant began radiation treatment part way through the NPW program and 
was not capable of completing the same amount of walking time, instructors modified the 
program to ensure participants were able to continue NPW. 
The NPW program consisted of one supervised group NPW session per week held 
at one of two community recreational centres in the GTA. The group session was 
supervised by a trained instructor who was certified to teach NPW. NPW instructor training 
was provided for a research assistant who then assisted with facilitating the NPW program. 
The training was led by a physiotherapist who provided background information about the 
benefits of NPW followed by a practical, hands on workshop on instructing the proper 
NPW technique. During the group sessions at the recreational centres, the instructor 
corrected technique, monitored participants’ progression according to the pre-determined 
exercise prescription, and addressed any questions or concerns raised by participants. 
Participants were told to immediately report any abnormal responses that they experienced 
when exercising to the research team. Additional supports were utilized by participants 
(such as oxygen, tables, walls, and chairs) when necessary. Throughout the remainder of 
each week, participants completed up to three independent NPW sessions at home or at the 
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community recreational centre. Participants were provided with written instructions on 
how to NPW (Appendix M) and NPW instructors shared their contact information so that 
participants could ask questions or address concerns when completing the NPW sessions 
independently.  
To promote program adherence, several recommended behavioural change 
techniques (Bourke et al., 2013) were incorporated into the NPW program. This included 
goal setting, self-monitoring, practicing, and generalizing behaviour to other non-
supervised contexts. Participants were asked to write out their motivation behind taking 
part in the NPW program and to set exercise related goals prior to beginning the NPW 
program (Appendix N). Documentation of program adherence is critical to understanding 
treatment dose (Bourke et al., 2013). Therefore, each time participants completed a NPW 
session (supervised or at home) they were asked to make an entry in a journal (Appendix 
E) reporting distance walked, duration, and RPE. On days when participants did not 
complete a NPW session they were asked to record the reason that they were not able to 
walk. The research team offered to contact participants weekly by phone or email 
(according to their preference) to encourage and support participation. At the end of the 
program participants reflected on the goals they had set to see how close they were to 
achieving them. 
The control group was instructed to continue their usual daily routine (i.e. activities 
of daily living) for eight-weeks and was provided the opportunity to participate in the same 
NPW program after this time period. The research team did not contact individuals in the 
control group during the eight-week period and no data was collected on their daily routine 
other than the documentation of planned exercise participation that was mentioned earlier. 
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3.4 Data Analysis 
3.4.1 Feasibility 
 
 All feasibility outcomes were documented as the study progressed. There was no 
formal interpretive qualitative analysis done as this was beyond the scope of the study. The 
research team met periodically to assess the ongoing feasibility of the study and 
adjustments to the protocol were made as needed. Between meetings if the lead researcher 
noticed issues with completing the protocol, they would consult with the research team. 
For example, if there were issues with recruitment, it was brought up with the research 
team and actions were taken to improve the recruitment rate. At the end of the study, all 
the documents were summarized and categorized according to the four feasibility criteria 
(Thabane et al., 2010). Ultimately, the outcome of the pilot study (stop; continue, but 
modify the protocol; continue without modifications, but monitor closely; or continue 
without modifications) was based on the judgement of the research team. 
3.4.2 NPW Outcomes 
 
 Descriptive statistics (mean, median, and standard deviation) were calculated for 
numeric data. Non-parametric tests were used to compare the intervention and control: a 
Wilcoxon signed-rank test to see if changes occurred over time, and a Mann-Whitney U 
test to see if there was a difference between groups (pre, post, and effect sizes). A p-value 
of less than 0.05 was considered significant. Non-parametric tests were selected for two 
reasons. First, two assumptions for parametric tests (such as ANOVA) require the data be 
normally distributed with no significant outliers. It was uncertain if these assumptions were 
met due to the small sample size. Secondly, non-parametric tests are more conservative 
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analyses and may detect true differences i.e. result in less Type I error IBM SPSS Version 










































4.1 Feasibility Analysis 
 
The following is a description of the study design, operation, and feasibility with reference 
to the four criteria of the Thabane Framework (Process, Resources, Management and 
Scientific) as described in Section 3.3.1. 
4.1.2 Inclusion/Exclusion Criteria 
(Objective: Process) 
Initially, researchers were only considering individuals diagnosed with non-small 
cell lung cancer (NSCLC). After four-months the initial recruitment yielded only two 
participants, and therefore, the research team decided to broaden the inclusion criteria to 
accept individuals with prostate cancer, colorectal cancer, or endometrial cancer. This 
change in recruitment criteria did, in fact, facilitate recruitment. After two months, six new 
participants were enrolled in the study. Alternatively, the study design could have been 
changed to a pre-post design with the NSCLC population only. However, researchers were 
not certain an adequate number of patients with NSCLC would be recruited even for this 
design. Figure 4 provides a more specific timeline of participants’ enrollment. The altered 
inclusion criteria were still discriminative because some individuals were excluded from 
the study. For example, some individuals were excluded because they had an ineligible 



















Figure 4. A detailed timeline indicating when recruitment began, when changes were 
made in inclusion/exclusion criteria and when participants enrolled in the study. 
Note: *recruited through hospital cancer centre, **recruited through word of mouth, † 
recruited through support group email, ‡ recruited through support group meeting, § 
recruited through poster displayed at cancer support centre 
4.1.3 Recruitment Rate 
(Objectives: Process and Resources) 
 
 Due to time constraints, we were not able to reach the projected sample size of 20 
participants. A total of 18 potential participants were contacted about the study and of 
those, two individuals did not meet the eligibility criteria. One individual had been 
diagnosed with prostate cancer more than three years ago and the other was diagnosed with 
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(n=9). Reasons for declining participation included having a busy schedule, already 
participating in other physical activities, travelling for an extended period of time, and 
living too far away from the location where the study was taking place. See Figure 5 for a 



















































Figure 5. A flow diagram of participants through the pilot study from first contact to final 
assessment. 
Note: The recruitment rate is 50% and the completion rate is 77.78%. 
Jan-Aug 2016 
Potentially eligible 
participants contacted n=18, 
n = 9 NSCLC, n = 6 prostate 
n = 1 colorectal 
n = 1 endometrial 
n = 1 breast 
 
Excluded n = 2, Reasons: 
diagnosed with prostate cancer 
more than 3 years ago (n = 1), 
diagnosed with breast cancer  
(n = 1) 
 
Declined n = 7, Reasons: 
busy schedule (n=2), 
already participating in 
physical activity (n=2), 
travelling (n=1), lived too 
far away (n=1), no answer 
(n=1) 
Participants recruited n = 9,  
n = 5 with NSCLC 
n = 2 with prostate cancer 
n = 1 with colorectal cancer 
n = 1 with endometrial 
cancer Dropped out n = 1, unsure about ability to participate 




Initial Assessment n = 8, 
Participants randomly allocated 
 
NPW Group n = 4 
 
Control Group n = 4 
 
Dropped out n = 1,  
due to sudden bereavement 
 
Final Assessment n = 3 
 




4.1.4 Recruitment Procedures 
(Objective: Process) 
 
Recruitment of individuals with NSCLC was considerably more challenging than 
expected. In the GTA, there are very few (if any) support groups and rehabilitation 
programs for individuals coping with lung cancer. This may be due to a poor prognosis 
since most individuals are not diagnosed until the later stages of the disease when they may 
not be well enough to participate. Thus, researchers had to rely heavily on recruitment at 
both hospital sites and could not be actively involved in the day-to-day recruitment 
procedures. 
Once researchers obtained approval from the Research and Ethics Board to begin 
recruiting individuals with prostate cancer, colorectal cancer, or endometrial cancer (in 
June), recruitment was more successful. Researchers were able to contact patients who had 
been diagnosed with prostate cancer or colorectal cancer through support groups. Also, 
patients with these types of cancer were more likely to attend programming at the cancer 
support centres. 
Table 4 provides information about recruitment method success rates. The process 
for each recruitment method is then discussed in detail. 












Hospital 7 4 57 
Posters 3 1 33 
Social Media 0 0 0 
Support Groups 7 3 43 




4.1.4.1 Hospital Recruitment 
At the Community Hospital 1, no participants were recruited for the pilot study and 
in fact, no inquiries were received from Community Hospital 1 patients. Initially, 
physicians at the Community Hospital 1 Cancer Centre were informed about the pilot study 
during a presentation at the monthly lung rounds. During this first meeting the physicians 
asked questions, provided feedback, and agreed to assist with recruitment, indicating that 
recruiting participants with NSCLC for the study should be easy. Unfortunately, from the 
time of the preliminary discussion with the physicians, to the submission and approval of 
the Research and Ethics Board application, research personnel in the hospital changed and 
this negatively affected the recruitment process. During preliminary talks, hospital staff 
agreed that researchers were welcome to be on site at the hospital to recruit patients. 
However, with staff changes, the final recruitment process that was agreed upon relied on 
a team of approximately 15 nurses to inform and recruit potential study participants with 
NSCLC. After receiving the information, it then became the responsibility of the 
individuals who were interested to contact researchers. This did not allow researchers to 
develop any rapport with the patients or staff.  Moreover, a hospital research staff member 
mentioned that Community Hospital 1 undertakes multiple randomized controlled drug 
trials and that this "competition" may have contributed to poor recruitment. Finally, no one 
at the Community Hospital 1 site served to champion the recruitment process, and 
therefore, the study was not the focus of nurses and physicians during their daily activities.   
At the Community Hospital 2 participant recruitment was more successful. Four of 
the five individuals with NSCLC were recruited from the Community Hospital 2. One 
individual with NSCLC heard about the study by word of mouth. Although researchers 
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were not on site to recruit participants, a medical oncologist, and two nurses championed 
the study. They were enthusiastic about the research, and communicated consistently with 
researchers. Once the study was complete, researchers discussed the recruitment process 
with the nurses to obtain feedback. Overall the nurses felt that recruitment minimally 
impacted their daily work routine. They mentioned the importance of having the study 
information sheet visible so that they were reminded regularly of the study. The biggest 
recruitment challenge mentioned was the timing of providing the NPW study information 
to the patients. Many patients are overwhelmed as they are coping with a new cancer 
diagnosis, multiple medical appointments, new treatment, and not knowing what side 
effects they may experience due to the cancer or treatment. For this reason, the nurses 
discussed the study during the initial appointment and then approached the patients again 
about the study a few weeks later.  
4.1.4.2 Posters 
The posters displayed at community recreation centres and cancer support centres 
were somewhat successful in recruiting individuals for the study. Only one potential 
participant with NSCLC heard about the study from a poster displayed at a cancer support 
facility in Ottawa. Unfortunately, because of the travel distance to the GTA this individual 
declined participation. Another individual who was diagnosed with endometrial cancer was 
successfully recruited after seeing a poster that was displayed at the Wellspring Cancer 
Centre in Toronto. Program organizers at the various centres disclosed that individuals with 
NSCLC do not often participate in their programs and therefore, it is unlikely that they 
would have seen the posters. 
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4.1.4.3 Social Media Recruitment 
Social media was used to reach out to individuals within the NSCLC community, 
including clinician experts, professional societies, and patient advocacy groups. The 
inability of researchers to create an online presence resulted in poor recruitment through 
social media. Information that was tweeted out at regular intervals did not get retweeted by 
key organizations or people. Even though individuals who have NSCLC are not likely to 
be on social media, it was hoped that the health professionals, care givers, friends, and 
family of these individuals would see the posts. 
4.1.4.4 Cancer Support Groups Recruitment 
Individuals with prostate cancer were recruited through two support groups (one in 
York Region, one in Durham Region). These groups usually meet face-to-face once a 
month, except during the summer (when the intervention took place). Instead, researchers 
emailed information about the study to members of the support groups. Six potential 
participants with prostate cancer contacted researchers and two of these individuals 
enrolled in the study. 
The NPW study was presented in person to the colorectal cancer support group in 
the Durham region. Four members of the support group attended the meeting and one 
individual was recruited. Attendance at the meeting was low because it was held during 
the summer months.  
No support groups or rehabilitation programs could be located for individuals with 
NSCLC or endometrial cancer. 
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4.1.4.5 Snowball Referrals Recruitment 
An article (Cunningham, 2016) about the study that was published in the 
professional development publication for Ontario Respiratory Care Society yielded no 
referrals. Neither did the emails that were sent to oncology surgeons, physiotherapists, 
kinesiologists, and massage therapists within the cancer care community. 
We provided information about the study to seniors within the community, but were 
unsuccessful in recruiting individuals with NSCLC. Most seniors within the community 
did not know of anyone with lung cancer, and those who did know someone with lung 
cancer were uncomfortable with sharing the information about the study with that person 
because they believed them to be incapable of participating in a walking program.  
One person who found out about the study through word of mouth referred a friend 
who had lung cancer to the study. The referrer had more knowledge about the importance 
of exercise to individuals with cancer compared to the general public and also had hands 
on experience using the Nordic walking poles.  
One study participant with NSCLC mentioned having a friend with lung cancer 
who might be eligible to participate in the study. However, this participant felt 
uncomfortable mentioning the study to her friend because she felt that her friend was 
experiencing worse symptoms than herself, making her friend unable to participate.  
4.1.5 Attrition 
(Objectives: Process and Resources) 
 
Two participants withdrew from of the study. One did so before the initial 
assessment because she was unsure of her ability to participate after having been informed 
of new cancer tumour growth. Another person who was randomly allocated to the NPW 
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group withdrew after the second week of participating in the intervention due to sudden 
bereavement. 
4.1.6 Participant Characteristics  
(Objectives: Process) 
 
The average age of participants (n=8) who enrolled in the study was 67 years of 
age (standard deviation (SD) 5.8). The youngest was 59 years old and the oldest was 75 
years old. Four participants were diagnosed with NSCLC, two were diagnosed with 
prostate cancer, one was diagnosed with colorectal cancer and one was diagnosed with 
endometrial cancer. Participants had been diagnosed with cancer on average 27.4 months 
prior to our initial assessment (range 3.8 to 43.1 months).  
Seventy-five percent (6 of 8) of the participants in the study were female, half of 
the sample lived alone, and 37.5% of the sample were widowed. None of the participants 
smoked at the time of the study, but 75% of them had previously smoked. The average 
(SD) duration of smoking for former smokers was 31.3 (19.9) years and they had quit 16.2 
(15.1) years ago. There were no statistical differences in baseline characteristics between 















Table 5. Participant’s Baseline Demographics, Cancer Diagnosis, Treatment, and 
Smoking Status 
Variable NPW 
N = 4 (%) 
Control  
N = 4 (%) 
Total 
N = 8 (%) 
Females 2 (25) 4 (50) 6 (75) 




Lives Alone 3 (37.5) 1 (12.5) 4 (50) 
Lives with Spouse / 
Partner 
1 (12.5) 2 (25) 3 (37.5) 
Lives with Sister 0 (0) 1 (12.5) 1 (12.5) 
Marital Status 
 
Married / Common Law 0 (0) 1 (12.5) 1 (12.5) 
Never Married 0 (0) 2 (25) 2 (25) 
Divorced / Separated 2 (25) 0 (0) 2 (25) 
Widowed 2 (25) 1 (12.5) 27.5 
Education 
 
High School or Less 2 (25) 0 (0) 2 (25) 
Any Vocation / College 1 (12.5) 2 (25) 3 (37.5) 
Any University 1 (12.5) 2 (25) 3 (37.5) 
Employment Retired 3 (37.5) 2 (25) 62.5 
Full-time 0 (0) 2 (25) 2 (25) 
Part-time / Casual 1 (12.5) 0 (0) 1 (12.5) 
Household 
Income 
$25,000 to $45,000 1 (12.5) 1 (12.5) 2 (25) 
$45,001 to $65,000 1 (12.5) 1 (12.5) 2 (25) 
More than, or equal to 
$65,001 
2 (25) 1 (12.5) 3 (37.5) 
Did Not Answer 0 (0) 1 (12.5) 1 (12.5) 
Type of Cancer Lung 2 (25) 2 (25) 4 (50) 
Prostate 2 (25) 0 (0) 2 (25) 
Colorectal 0 (0) 1 (12.5) 1 (12.5) 
Uterine 0 (0) 1 (12.5) 1 (12.5) 
Stage of Cancer 1b 0 (0) 1 (12.5) 1 (12.5) 
2a 0 (0) 1 (12.5) 1 (12.5) 
2b 2 (25) 0 (0) 2 (25) 
3a 0 (0) 2 (25) 2 (25) 
Prostate* 2 (25) 0 (0) 2 (25) 
Type of 
Treatment 
Surgery 1 (12.5) 3 (37.5) 4 (50) 
Radiation 3 (37.5) 3 (37.5) 6 (75) 
Chemotherapy 2 (25) 3 (37.5) 5 (62.5) 
Brachytherapy 1 (12.5) 0 (0) 1 (12.5) 





Yes 0 (0) 0 (0) 0 (0) 
Previously 
Smoked 
Yes 4 (50) 2 (25) 6 (75) 
*Note: Prostate cancer is graded differently than the other types of cancer. Doctors grade 
prostate cancer using the General Grading System or the Gleason Grading System. 
Participants in this study with prostate cancer were unsure of the grade of their cancer. 
 
Table 6. Participant Smoking Statistics 
Variable 
NPW N = 4 
Mean ± SD 
Control N = 4 
Mean ± SD 
Total N = 8 
Mean ± SD 
Number of Years of Smoking 31.3 ± 15.0 31.3 ± 26.5 31.3 ± 19.9 
Number of Years Since Quitting Smoking 18.7 ± 19.5 12.5 ± 10.6 16.2 ± 15.1 
 
All participants who received cancer related treatment experienced some side 
effects including: metastasis (1 of 8), lack of energy (1 of 8), fatigue (1 of 8), weakness (2 
of 8), pain (2 of 8), bruising easily (1 of 8), decreased bone density (1 of 8), difficulty 
coughing (1 of 8), increased coughing (1 of 8), dyspnea (3 of 8), constipation (1 of 8), 
urinary retention (1 of 8), headaches (1 of 8), neuropathy (1 of 8), and ear blockage (1 of 
8). Participants were also diagnosed with the following chronic health conditions: another 
type of cancer (2 of 8), food allergies (2 of 8), other allergies (4 of 8), asthma (2 of 8), 
arthritis or rheumatism (4 of 8), back problems (not arthritis or rheumatism) (4 of 8), high 
blood pressure (3 of 8), chronic bronchitis (1 of 8), chronic obstructive pulmonary disease 
(COPD) (2 of 8), diabetes (1 of 8), cataracts (3 of 8), glaucoma (1 of 8), multiple chemical 
sensitivities (1 of 8), dyslexia (1 of 8), heart murmur (1 of 8), and osteopenia (1 of 8).  
4.1.7 Location of Study 
(Objective: Management) 
 
Both the Community Recreation Centres were easily accessible for study 
participants and the staff at both centres were very friendly, accommodating, and easy to 
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communicate with on multiple occasions.  At Community Recreation Centre 1, the atrium 
was used to conduct assessments. The atrium had plenty of space, was fairly quiet, and 
there was a reasonable amount of privacy for the participants. At Community Recreation 
Centre 2 the space that was originally agreed upon for the assessment was no longer 
available due to renovations being done. Facility staff were very accommodating and 
arrangements were made to use the hall space near the information desk. For the 6MWT 
this space was not ideal because participants had to walk in the hallway that was also being 
used by people who were coming and going from the facility. Also, the area was fairly 
noisy and it lacked privacy.  
The NPW program at Community Recreation Centre 1 was conducted on a large, 
spacious track. Participants had enough space to walk beside someone else who was NPW 
and there was plenty of space off to the side of the track to do other necessary tasks such 
as sit and rest, do stretches, fill out paper work, and have discussions with participants. At 
Community Recreation Centre 2 the NPW program took place on a small track. The space 
worked, but participants were not able to walk beside someone else who was NPW and 
there was limited space off to the side of the track. Seating was limited so that during busy 
times participants had to wait for a seat to take a rest and at the end of the NPW session 
participants left the track area to go to a downstairs hallway to fill out their paper work and 
have any necessary discussions. Both facilities possessed sufficient outdoor space for 
walking (e.g. sidewalks in neighborhoods and trails in parks). For individuals with lung 
cancer the indoor facilities were ideal as walking outside makes breathing difficult 
especially during the very hot or cold weather.  
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To facilitate study participation, researchers went to the homes of some participants 
(n=2) who were located further from the recreational facilities. Assessments at home were 
easily conducted and as long as the weather was fair and conditions were safe, participants 
agreed to do the 6MWT outdoors. These participants were comfortable with NPW 
outdoors. Home visits were essential, since weekly supervision was not feasible and 
participants lived quite a distance from the track at the recreational facilities. 
4.1.8 Study Expenditures 
(Objectives: Resources) 
 The total cost of conducting the study from January to October 2016 was $3023.73. 
Researchers benefited from the donation of 15 poles by Nordixx Pole Walking 
Incorporated and from the discounted fees for passes at the community recreation centres. 
The initial cost for beginning to NPW is approximately $124.04 (Nordixx Walking Poles: 
$79.04, Private Instruction: $40.00, Walking Pass: $5.00).  Continued costs range from 
approximately $5.00 daily for a walking pass to $15.00 per class to attend group 











Table 7. Study Expense Report 
ITEM COUNT COST 
Community Recreation Centre 1 Passes (booklet) 100 $66.67 
Community Recreation Centre 2 Passes (booklet) 100 $500.00 
Printing (posters, information sheets, assessment 
documents) 
120 $90.00 
NPW Instructor Training 2 $250.00 
Poster and Information Sheet Stands 6 $40.00 
Duotangs 6 $12.00 
Dynamometer 1 $350.00 
Measuring Tape 1 $16.00 
Flexible Measuring Tape 2 $10.00 
Oxygen Saturation & Heart Rate Monitor 1 $25.00 
Digital Body Weight Scale 1 $20.00 
Plastic Stool 1 $25.00 
Pylons 12 $13.50 
Painters Tape 1 $19.50 
Masking Tape 1 $3.00 
Wooden Dowels (materials for UULEX weighted bar) 5 $25.00 
Foam Core Board (materials for UULEX wall-mounted 
board) 
2 $13.56 
Lentils (materials for UULEX weighted bar) 1 $2.00 
Duct Tape (materials for UULEX wall-mounted board) 1 $7.00 
Stop Watch 1 $30.00 
Clipboard 1 $7.00 
Mileage (50 cents per kilometre) 599 km $299.50 
 TOTAL $1,824.73 
TASK HOURS COST 
Data Collection 22.5 $495.00 
NPW Classes 32 $704.00 
 TOTAL $1,199.00 
GRAND TOTAL $3,023.73 
4.1.9 Exercise Adherence 
(Objectives: Process, Resources and Scientific) 
Due to small sample size, it is not possible to determine if NPW was more suitable 
for patients at a particular cancer stage or treatment. One participant with prostate cancer 
had brachytherapy treatment just prior to enrolling in the study, and then had radiation 
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treatment while participating in the NPW program. This participant mentioned the 
radiation treatment caused him to have problems with his bowels preventing him from 
NPW on some days when he had planned to walk. Despite this, he was able to adhere to 
the program by altering which days he completed the independent NPW sessions. Another 
participant in the control group was undergoing chemotherapy treatment for NSCLC while 
enrolled in the study. This participant was still able to complete the baseline and final 
assessments without difficulty.  
There was 100% adherence to the weekly supervised NPW sessions (for the 
intervention participants who completed the study; n=2 with prostate cancer, n=1 with 
NSCLC). Sessions were scheduled in advance and at a time that was convenient for the 
participant. The two individuals with prostate cancer walked an average of 4 times a week 
(once with NPW instructor, 3 times independently). The participant with NSCLC walked 
an average of twice a week (once with NPW instructor, once independently). Participants 
with prostate cancer were able to walk outside on their own whereas those with NSCLC 
walked at the community centre since breathing outside was often difficult. Walking on a 
level surface and having a place to sit when necessary also made walking more feasible for 
the individual with NSCLC. Two participants in the study experienced low back pain that 
was likely not related to the NPW. The instructors helped them to manage the pain with 
stretches and if the pain was great enough to prevent them from walking one day then these 
participants rescheduled their independent walk for another day. 
Individuals who had weekly supervised NPW sessions preferred not to have follow-
up phone calls or email contact. Having weekly contact with the NPW instructor was 
enough to keep participants motivated to walk regularly, though with a larger group, 
92 
 
weekly follow-up may be more important, since instructors would have less time with each 
individual participant during sessions. Instructors reminded participants of their motivation 
for taking part in the program and the goals that they had set before starting. Participants 
decided to take part in the NPW program to improve breathing (n=1), to improve endurance 
(n = 1), to lose weight (n = 1), to feel better (n = 1), to improve overall fitness level (n = 
1), to help with prevention of cancer growth (n = 1), and to return fitness levels to what 
they once were (n = 1). In the post-program survey one participant stated, “It (the program) 
was long enough to teach me a new habit of NPW daily.” This demonstrates that 
participating in the NPW program helped individuals incorporate regular exercise into their 
daily routine. After being in the control group, all participants took advantage of the 
opportunity to participate in the NPW program. Those who could not attend weekly 
supervised NPW sessions did rely on weekly contact with instructors by phone or email. 
Of the eight program participants (individuals in the NPW group and individuals in the 
control group who decided to do the NPW afterwards) six purchased a set of Nordic poles 
with the intention of continuing to walk independently. 
4.1.10 Safety 
(Objectives: Management and Scientific) 
 
 No adverse events occurred during the study. However, one individual in the 
control group and two in the NPW program did report pain during the study. They indicated 
that the pain experienced was not a result of their participation. The individual in the control 
group had chronic low back and hip pain, nevertheless she was still able to complete the 
assessment tasks without difficulty. One individual in the NPW group injured his low back 
when shoveling and lifting dirt and another in the NPW group had chronic low back pain 
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that he had been managing over a number of years. Regardless, both NPW participants 
were able to continue walking and if their back pain worsened, the NPW instructors guided 
them on technique and appropriate stretches.  
4.1.11 Intervention Evaluation 
(Objectives: Resources, Management and Scientific) 
 Nordic pole walking classes ranged from 20 to 70 minutes long with five to ten 
minutes of stretching upon completion. There was no set up or take down involved. 
Researchers took five to ten minutes at the end of each class to review participants’ 
progress and ensure they had a plan to complete their independent NPW sessions for the 
week. 
The NPW program was individualized to meet the needs of each participant so all 
participants were able to adhere to their program regardless of any cancer or treatment 
related side effects that they might have experienced. NPW instructors adjusted the 
prescribed NPW plan as needed. Both participants with prostate cancer were prescribed the 
‘Highly Active’ NPW program and both participants with NSCLC were prescribed the 
‘Inactive’ NPW program. Researchers successfully determined participants’ NPW 
prescription based on their IPAQ score and observed ability level. The 6MWT could have 
been used to determine overall fitness instead of the IPAQ; however, the IPAQ is practical 
and easy to conduct without the need for equipment or a 30-metre space. The IPAQ was 
also selected as an indicator of functional ability and fitness because of its capacity to 
measure overall daily activities based on real world conditions (effectiveness) compared to 
the 6MWT which is a clinical measure.  
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The individuals with prostate cancer did have an easier time with NPW compared 
to participants with NSCLC because their general fitness level was higher. The main 
challenge for the participants with NSCLC was managing their breathing.  Over the course 
of eight-week NPW program individuals were not walking faster, but their overall 
endurance throughout the session was improved. For example, one participant with 
NSCLC began week one with 20 minutes of NPW taking a break every 5 minutes and by 
the end of the eight-week program this participant was able to walk for 30 minutes without 
resting. 
Researchers observed that there is a training effect when learning to NPW for the 
first time, making it essential to provide participants with a week to practice walking with 
the poles prior to starting the study. Most participants were surprised by the concentration 
required to maintain proper technique in the beginning. A participant commented that they 
found it “challenging to learn the NPW technique because they had walked with the poles 
a few years ago using the incorrect technique.” Also, throughout the eight-week program 
NPW instructors continued to focus on ensuring the participants maintained proper walking 
technique. This was critical since the fatigue that results from longer periods of walking 
often compromises proper technique.   
The research assistant understood the NPW technique after training, but he did not 
feel that he had completely mastered it. After shadowing researchers during the first NPW 
sessions the research assistant became more comfortable with instruction and was able to 
hold classes on his own. The research assistant commented that more training on how to 
correct an individual’s gait patterns would have been helpful.  
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4.1.12 Assessment Procedures & Equipment 
(Objectives: Resources and Management) 
 
 Assessments took on average one and a half to two hours to complete. This was 
longer than researchers expected, but the extended time doing assessments enabled us to 
develop rapport and give support to participants as they shared their experience of being 
diagnosed with and treated for cancer. Participants with more aggressive forms of cancer 
took more time during the assessment to elaborate on their story. Some participants 
considered the baseline assessment to be too long, although all participants were able to 
complete the physical tests and questionnaires and they understood the importance of each 
test. The final assessment was completed in less time because the demographics 
questionnaire did not have to be completed and participants were already familiar with the 
assessment procedure. 
Researchers readily obtained the necessary testing equipment prior to conducting 
the study. For the UULEX a wall-mounted chart and weighted bars (0.2 kilograms (kg), 
0.5 kg, 1.0 kg, 1.5 kg, and 2.0 kg) had to be constructed according to the guidelines 
provided by Takahashi et al. (2003). Building these assessment tools took researchers about 
three hours. The assessment equipment was easily transported to the location where it was 
being used and the set up for each assessment took approximately half an hour. 
4.1.13 Suitability of Outcome Measures 
(Objectives: Scientific) 
The upper and lower body physical function assessment tasks were easily explained 
and completed. One participant with NSCLC did have to stop the UULEX because of 
underarm pain caused by a scar from lung resection surgery.  
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Questionnaires were completed by participants with the help of the researcher to 
ensure that they were completed in a timely manner. When completing the IPAQ some 
participants had difficulty recalling how much of the time they spent each day doing 
vigorous or moderate physical activities, walking, and sitting during that week. In addition, 
the wording of some of the questions in the SF-36 questionnaire required some 
clarification.  
The first participant with NSCLC who completed the FACT-L questionnaire 
refused to answer the last question about smoking regrets. This participant wrote on the 
questionnaire, “How insulting! How do you think I feel? If I had the information 40 plus 
years ago that is available now do you think I would have smoked?” As a result, researchers 
removed this question from subsequent questionnaires so that other participants would not 
become upset by it. It is likely this did not affect the results from the questionnaire since 
this question is not included in the scoring. In addition, the cancer specific aspects of the 
questionnaire did not pertain to the participants enrolled in the study since the questions 
related to individuals undergoing chemotherapy or radiation therapy. This is also the reason 
why other FACT questionnaires were not completed for the other cancer populations in the 
study. 
The changes in the 6MWT was not reflective of improvements that occurred in 
participants’ aerobic fitness. Over the eight-week NPW program, researchers observed that 
each participant’s pace did not change, while their overall endurance during the session 
improved. By the end of the program one participant with NSCLC who could only walk 
for five minutes at a time was able to walk for 30 minutes continuously. The scores for the 
6MWT did not reflect this improvement in overall endurance. 
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4.1.14 Data Collection 
(Objectives: Management) 
 
 Some alterations need to be made to the data collection sheets before a large-scale 
trial is conducted. These adjustments are required to correct errors that were made during 
the design of the data collection sheets and to allow for some additional data to be obtained 
during the assessment. Changes required for the initial and final assessment forms include:  
1)   Adding a second measurement for biceps (left and right) and thighs (left and right).  
2)   Adding fatigue and dyspnea measures for before and after both the 6MWT and the 
UULEX.  
3)   Providing a space to record the heart rate and oxygen saturation levels after the 
6MWT.  
4)   Removing the second trial time for the UULEX.  
5)   Providing a space to indicate the highest level that participants can reach for the 
UULEX. 
Participants completed the weekly exercise tracking sheets correctly suggesting 
that they do not need to be modified. In the post program survey, all participants indicated 
that the journal was informative and useful. A space could be provided for participants to 
document challenges that they may have experienced while NPW each day (e.g. shortness 
of breath, back pain, etc.). This would assist NPW instructors with helping participants 
overcome these challenges during the program and promoting their success. 
4.1.15 Participant Feedback 
(Objectives: Management and Scientific) 
 The participant feedback collected from the post-program survey was generally 
positive. Participants indicated that they enjoyed the program, that the instructors were 
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encouraging and supportive throughout, and that they benefited from taking part in the 
study. One participant stated, “It (NPW) made me want to exercise and gave me more 
energy.” Another participant remarked, “I believe that in a way it (NPW) changed my life. 
Now I have an activity which I can continue on a daily basis as long as I am able to. It 
improved not only the physical side, but most importantly the mental, emotional - my 
internal side!” Some of the challenges mentioned by participants included overcoming 
fatigue, managing unrelated pain, learning the NPW technique, and time management. For 
all a detailed list of responses to the open-ended survey questions see Appendix O. 
4.2 NPW Outcome Analysis 
4.2.1 Anthropometric Measures 
 
At the baseline assessment half of the participants (n = 4) had a BMI of 25 or higher, 
classifying them as overweight or obese and at increased risk of developing health 
complications (Canadian Society of Exercise Physiology, 2013). All of the female 
participants (n=6) had a waist circumference of 80 centimeters or higher. Having a waist 
circumference greater than 80 centimeters means these women are at an increased risk for 
diabetes, coronary heart disease, and hypertension (Canadian Society of Exercise 
Physiology, 2013). For men, the cut off value for waist circumference is 90 centimeters. 
One male participant had a waist circumference above this value and the other male 
participant had a waist circumference below this value (Canadian Society of Exercise 
Physiology, 2013). The participants that were in the NPW group experienced a significant 
decrease in thigh circumference measurements from the baseline assessment (Right Thigh: 
median 49.4 cm (range 8.7); Left Thigh: median 49.0 cm (range 6.0)) to the final 
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assessment (Right Thigh: median 48.5 cm (range 6.5); Left Thigh: median 46.3 (range 4.0)) 
(p<0.05). No other significant change in body weight, or circumference measurements 
occurred between the two groups, over the eight-week period. Refer to Table 8 for detailed 






















Table 8. – Anthropometric Measures, Heart Rate, and Oxygen Saturation Levels by 
Group 














































































































































































































































*p<0.05 significant within group difference between baseline assessment and final 
assessment 





4.2.2 Physical Activity Levels, & Lower Body & Upper Body Physical Function 
 
 The total amount of energy expended during walking, moderate-intensity activities 
and vigorous-intensity activities during the week was calculated based on the self-reported 
IPAQ questionnaire. The mean (SD) physical activity levels of participants in the NPW 
group improved, but was not statistically significant (baseline: 2346.0 Met-min/week 
(2532.6); final: 5051.0 Met-min/week (3455.7)), while the physical activity level of 
participants in the control group declined (baseline: 4419.0 Met-min/week (4021.9); final: 
1743.3 Met-min/week (1987.0)). A significant improvement was found in the 30-s chair 
stand test (p<0.05), but no change occurred in the 6MWT. There was no improvement in 
upper body physical function (grip strength and UULEX). The mean duration (SD) of the 
UULEX test in healthy Canadian females age 60 to 69 is 12.54 minutes (2.0) (Lima et al., 
2017). In males age 60 to 69 the mean duration (SD) was 13.15 minutes (1.67) (Lima et 
al., 2017). The mean duration for the UULEX test for participants in this study was close 
to these norms.  No statistical difference between groups was found, but there was a 
significant trend in the effect sizes (pre-post differences) between the IPAQ for moderate 
activities (-8.3 (22.5) NPW versus -102.5 (91.8) control, minutes), IPAQ for walking 
activities (118.3 (106.8) NPW versus -47.5 (37.7) control) and total METS-min/week 
(1956 (1635) NPW versus -2675.8 (2124.4) control), p=0.057. See Table 9 for more 
detailed information comparing the NPW group to the control group. Refer to Table 10 & 






Table 9. – Physical Activity Levels, and Lower Body and Upper Body Physical Function 
Results 









































































































































































































































2.3 (1.5) 2.0 (3.0) 1.8 (1.9) 1.0 (3.5) 2.7 (0.6) 3.0 (1.0) 2.0 (0.8) 2.0 (2.0) 
*p<0.05 significant within group difference between baseline assessment and final 
assessment 
 
Table 10. – Physical Activity Levels by Participant 
 
ID 
METS Total Score (Met-min/week) 
Baseline Assessment Final Assessment 
1NPW 99 --- 
4NPW 240 1244 
6NPW 4899 5919 
9NPW 4146 7990 
2C 3159 1758 
5C 2226 370 
7C 10398 4548 
8C 1893 297 
 
Table 11 - Differences in Individual Vigorous, Moderate, Walking, and Sitting Activity 
between Baseline and Final Assessments 
ID 
Difference in  
Met-min/week 
Vigorous Activity 









4NPW 0 80 924 -240 
6NPW -480 -480 1980 -180 
9NPW -1760 60 5544 60 
2C 720 -240 -1881 -60 
5C -120 -680 -1056 255 
7C -720 -2160 -2970 120 
8C -720 -480 -396 60 
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4.2.3 Health-Related Quality of Life 
 
Results from the SF-36 questionnaire indicated a trend towards improved HRQoL 
in the participants in the NPW group compared to the control group (Table 9). More 
specifically, the mean values of each domain in the SF-36 stayed the same or improved in 
the NPW group whereas in the control group most of these values decreased and any 
improvement that occurred was less than the NPW group with the exception of the domain 
assessing pain (Figure 6). There was no statistical difference between groups. The NPW 
group experienced an improvement in mean scores (SD) for the Role Limitations Due to 
Emotional Health domain (baseline: 55.6 (50.9); final: 100.0 (0)), the Emotional Well-
being domain (baseline: 74.7 (8.3); final: 88.0 (8.0)), and the Energy and Fatigue domain 
(baseline: 61.7 (23.6); final: 73.3(20.8)), while the control group declined in these 
categories (Role Limitations Due to Emotional Health – baseline: 66.7 (38.5); final: 50.0 
(43.0); Emotional Wellbeing – baseline: 75.0 (17.7); final: 74.0 (16.8); Energy and Fatigue 
– baseline: 57.5 (19.4); final: 53.8 (22.1)). The SF-36 values of study participants at 
baseline were below Canadian normative values for this age group (65 to 75 years old) 
(Hopman et al., 2000). After participating in the eight-week NPW program the SF-36 
values of participants at final assessment were above the Canadian normative data except 
in the domains measuring Physical Function and General Health. Refer to Table 12 and 







Table 12. – SF-36 Questionnaire Results 
 NPW Control Canadian 
Normative 
Values 























































































































































*Note: B:Baseline; F:Final 
**Note: Data from Canadian Normative Data for the SF-36 Health Survey, Canadian 





Figure 6. A graph of the mean difference between the baseline and final SF-36 scores. 
 
Only three participants with NSCLC completed the study limiting the data that was 
obtained from the FACT-L questionnaire. Individual FACT-L scores that are displayed in 
Table 13 and 14 show that the one participant with NSCLC who completed the NPW 
program had improved HRQoL when subscales were combined to calculate the Total 
Outcome Index (TOI) score, the FACT- G score and FACT-L score. In comparison, the 
two participants with NSCLC in the control group experienced a decline in HRQoL over 
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Table 13. – FACT-L Questionnaire Domain Results by Participant at the Baseline (B) 












Note: PWB – Physical Well-Being; SWB – Social/Family Well-Being; EWB – 
Emotional Well-Being; FWB – Functional Well-Being; LCS – Lung Cancer Subscale 
 
Table 14 - FACT-L Questionnaire Total Scores by Participant at the Baseline (B) and 
Final (F) Assessments  
ID 
TOI 
Score Range:  
0 to 84 
FACT-G 
Score Range: 
0 to 108 
FACT-L 
Score Range: 
0 to 136 
B F B F B F 
2C 50 48 76.5 72.7 76.5 72.7 
5C 75 70 102.8 99 102.8 99 
4NPW 54 62 84 85 84 85 




































0 to 28 
B F B F B F B F B F 
2C 19 18 24.5 25.7 19 13 14 16 17 14 
5C 26 23 26.8 28 24 24 26 24 13 23 





The discussion is separated into two sections. The first section focuses on the 
feasibility of the study and describes the modifications and recommendations aimed at 
improving study and program design for future studies and clinical practice.  These relate 
to the process, resources, management, and scientific objectives previously identified. 
Researchers considered these objectives when determining the outcome of the study out of 
four possibilities (1) stop – the study is not feasible; 2) continue, but modify the protocol – 
the study is feasible with modifications; 3) continue without modifications, but monitor 
closely – the study is feasible with close monitoring; and 4) continue without modifications 
– the study is feasible as is.) The next section considers the outcome measures with the 
understanding that the focus of a pilot study is on feasibility and not on testing intervention 
effectiveness (Tickle-Degnen, 2013).  
5.1 Feasibility 
Based on the Thabane et al. (2010) framework, the pilot study suggests that 
examining the effects of NPW on individuals diagnosed with NSCLC, prostate cancer, 
colorectal cancer, and endometrial cancer is feasible with modifications. Analysis of the 
study methodology resulted in the identification of various study facilitators and a number 
of potentially modifiable barriers (Table 15) that support this conclusion. Furthermore, 







Table 15. – Study Facilitators and Barriers 
 
In the future, researchers could decide to perform a large-scale randomized 
controlled trial (RCT) or an effectiveness trial. If researchers decide to perform an RCT, 
then consideration should be given to the sample size and homogeneity of the population 
being studied to minimize bias and ensure the sample population is representative of 
general population. Larger sample sizes have been recommended in similar NPW studies 
where recruitment has also been a challenge (Fritschi et al., 2012a; Jastrzebski et al., 2015; 
Malicka et al., 2011; Sprod et al., 2005). Furthermore, in this pilot study individuals with 
different types of cancer experienced different side effects that affected their physical 
Facilitators Barriers 
•   relationships with community 
recreation centres 
•   appropriate space at community 
recreation centres (accessible, 
quiet, private, and spacious) 
•   behavioural change techniques 
assisted with program adherence 
(goal setting, self-monitoring, 
practice, and generalizing 
behaviours to non-supervised 
contexts) 
•   individualized NPW 
prescription 
•   rapport established with 
participants 
•   NPW instructor training 
•   assessment equipment easily 
obtained, transported, and set up 
•   supervised NPW classes 
•   type of exercise – enjoyed, 
inexpensive, easily learned, can 
be performed anywhere, and 
safe 
•   type of cancer (higher symptom 
burden more difficult to participate 
in exercise) 
•   recruitment process 
•   unable to organize group NPW 
sessions 
•   accuracy of daily physical activity 
measures 
•   outcome measures (HRQoL and 




fitness level to a varying degree. To more accurately determine how NPW affects 
individuals with cancer, it is essential to ensure the population being studied is as 
homogeneous as possible and therefore, individuals with one specific type of cancer should 
be studied. Conducting an RCT would provide researchers with the knowledge of how 
NPW specifically effects individuals with certain types cancer.  
When an RCT may be difficult to organize, researchers may choose to run a patient 
preference trial. During a patient preference trial participants are able to select their desired 
treatment or those who do not have an opinion on which treatment they receive are 
randomly allocated into one treatment group or another (Torgerson & Sibbald, 1998). At 
least two analyses should be completed: one comparing randomised participants between 
the treatment groups and the other (comparing non-randomized treatment groups) treated 
like an observational trial, including adjusting for confounders. (Torgerson & Sibbald, 
1998). While patient preference trials do not replace RCTs, they do allow researchers to 
measure the acceptability of the treatment options that are available (Torgerson & Sibbald, 
1998).  
Another perhaps more practical option for studying NPW and the cancer 
population, may be to continue with an effectiveness trial. This type of a quality 
improvement study would be performed in a specific clinical or community setting as a 
program evaluation tool. Examining NPW for individuals with cancer in a specific location 
would allow researchers to take into consideration the staff, setting, resources, safety and 
priorities that are unique to the program location (Ogrinc et al., 2017). This option would 
provide researchers with the opportunity to compare NPW to other interventions that are 
the current standard of care within the clinical or community setting with the goal of 
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improving healthcare (Ogrinc et al., 2017). The disadvantage of this approach is that it does 
not let us determine the specific effect of NPW on the cancer population. 
 To inform future research and clinical practice, it is valuable to reflect on the design 
and operational processes of this study.  The following discussion considers the facilitators 
and barriers of the study that were presented earlier in Table 15. 
 Participant recruitment was one of the greatest challenges in ensuring the success 
of this pilot study. This is not uncommon in health research, especially research that 
involves participants diagnosed with cancer or other chronic diseases (Miller, Bakas, 
Buelow, & Habermann, 2013; Payne & Hendrix, 2010; Sygna, Johansen, & Ruland, 2015). 
Sully, Julious, and Nicholl (2013) reported that only 55% of studies involving health-
related research reached their target sample size. Due to the difficulty in recruiting 
participants with NSCLC, modifications to the inclusion and exclusion criteria were 
necessary to achieve a large enough sample. The recruitment of individuals diagnosed with 
NSCLC was especially challenging because patients experience a high symptom burden 
and their prognosis is frequently poor. Despite the increasing evidence supporting the 
benefits of exercise in this population, exercise is not yet included in standard care. Also, 
it often is difficult to connect with patients who have NSCLC since there are limited 
support groups and rehabilitation programs for this population. In studies on individuals 
with chronic diseases such as cancer and heart disease, this problem of establishing initial 
contact with potential participants is frequently reported (Miller et al., 2013). Determining 
and instituting optimal recruitment methods in studies examining the effects of exercise on 
individuals with NSCLC is crucial since systematic reviews have acknowledged the need 
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for larger study sample sizes (Cavalheri et al., 2013; Crandall et al., 2014; Granger et al., 
2011).  
In this pilot study, several recruitment methods were used, some of which were 
more successful than others. Social media and cancer support groups have the potential to 
be effective strategies for participant recruitment, but there are some important elements to 
consider. While social media may be a cost-effective method for recruitment, significant 
time and effort is needed to have a substantial and effective online presence (Khatri et al., 
2015; Miller et al., 2013; Sygna et al., 2015). If social media is to be used for participant 
recruitment, then the groups of interest must be clearly identified and a structured 
framework such as the one developed by Khatri et al. (2015) needs to be followed. This 
framework uses Twitter, Facebook, and YouTube and involves creating content ahead of 
time, maintaining an updated presence, and responding in a personal and timely manner to 
continually engage social media users (Khatri et al., 2015).  
With respect to cancer support groups, it may be worthwhile for researchers to 
establish a relationship with these groups. Having the opportunity to meet potential 
participants in person is valuable, since face-to-face interaction allows the researcher to 
address any questions and concerns about the study immediately and trust between the 
patient and researcher can begin to be established (Sygna et al., 2015). Consideration 
should be given to avoid recruitment through support groups during the holiday months, 
since meetings may not be held, and for those meetings that continue to run attendance is 
often low.  
Hospital-based recruitment has the potential to be a highly successful recruitment 
method and it remains the preferred method for recruiting individuals with NSCLC. 
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Fundamental to hospital-based recruitment is establishing a strong relationship with the 
oncology health team. Researchers must educate the team on the importance of exercise-
related research and how exercise is associated with increased fitness levels, strength, 
HRQoL, and improved symptoms in patients with cancer (Granger et al., 2017). This would 
empower the oncology health team and assist them in educating their patients about the 
benefits of exercise. Patient education has been identified as a barrier to exercise 
participation within the cancer population (Fernandez et al., 2015; Granger et al., 2017). 
Personal communications with experienced researchers in this field, located in Quebec 
(Coats et al., 2014) and Australia (Cavalheri et al., 2013) support these findings, as they 
emphasize how imperative it is that researchers develop a strong relationship with the staff 
who have direct contact with the patients. To ensure the success of future similar research 
trials, it is recommended that researchers identify organizations that align with their 
research goals of encouraging exercise participation to improve the HRQoL of patients. 
Researchers must then work to establish relationships with oncology leads within these 
organizations as early as possible in the research process. If the research goals of both 
parties do not align then researchers should look for ways to establish better collaborations 
or find other organizations to align with. 
 The recruitment procedures at the hospital must be well organized and researchers 
need to ensure that the workload and time of hospital staff is minimally affected. Physicians 
report that heavy patient loads mean there is limited time to discuss study participation 
with patients (Miller et al., 2013; Payne & Hendrix, 2010). During the pilot study oncology 
nurses introduced the study to potential participants during their first appointment and then 
followed up at a later date. During follow up discussions with the nurses it was suggested 
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that physicians should initially inform the patient about the study. The thought behind this 
proposal, is that the physician’s endorsement of the exercise program may result in patients 
having more confidence in their ability to participate and that they may take this 
recommendation more seriously. Future studies should explore this option.  
Being diagnosed with cancer is overwhelming for most and has been identified as 
a potential barrier to exercise participation in the NSCLC population (Granger et al., 2017). 
As individuals begin to come to terms with their diagnosis and what it means, they must 
also find time in their schedule for a number of health-related appointments. This coupled 
with the uncertainty of what the future holds in terms of their health and how they will 
manage is a constant concern, especially for those newly diagnosed with cancer. Providing 
clarity about the ability level needed to participate in the intervention and the time 
commitment involved in the study is important.  
Physicians may be hesitant to suggest that patients enroll in the studies because of 
concerns that study participation may cause undue harm to those who are already 
experiencing a decline in functional status (Payne & Hendrix, 2010).  To overcome this 
barrier and increase recruitment in future trials, frequent face-to-face interaction between 
clinical staff and researchers (or cross-appointed scientists) is necessary. Addressing 
questions regarding study participation on a regular basis may alleviate any concerns that 
physicians have. 
 Having the appropriate space to administer a NPW program is essential to its 
success. Strategic relationships with community facilities should be established early on in 
the organizational process of the study. Consideration should be given to the amount of 
space available, noise levels, privacy, and the accessibility of the facility. Researchers must 
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also ensure that there is good communication with facility staff and that they are willing to 
work with researchers to make certain that the study is a success. Conducting assessments 
and NPW at home was determined to be feasible and future studies may want to incorporate 
this into study procedures to facilitate greater study participation. Given that NPW can be 
performed in various settings, it is an adaptable exercise solution that has the potential to 
meet the need for long-term exercise interventions that continue to encourage the 
maintenance of physical activity levels in individuals with cancer after program 
participation (Jankowski et al., 2014; Spark, Reeves, Fjeldsoe, & Eakin, 2013). This is 
supported by the fact that 75% of the participants in the NPW program purchased Nordic 
poles upon completion. Future studies should assess NPW for its ability to facilitate 
continued exercise participation. 
Adherence to the NPW program was high, likely because researchers followed the 
recommendations to individualize the exercise prescription and integrate several 
behavioural change techniques into the program design (Bourke et al., 2013). The 
behavioural change techniques included goal setting, self-monitoring, practicing, and 
generalizing behaviour to other non-supervised contexts. Given the success of these 
behavioural change techniques, perhaps, a more formal behaviour change framework could 
be considered. Individualizing the program allowed the NPW prescription to be designed 
around the participant’s capabilities, making it more manageable while also improving 
adherence. Instructors regularly reviewed the exercise journals with the participants to 
review goals, discuss progress, address any difficulties, and adjust the exercise prescription 
appropriately. The exercise journals were regularly used by participants serving as a key 
learning tool throughout the NPW program. Providing individual participants with weekly 
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follow-up with instructors is necessary whether in person, by phone, or by email. Future 
studies should consider this, as it allows individuals an opportunity to ask questions and 
helps encourage them to stay on task. Most individuals with cancer do not meet current 
exercise recommendations (Fernandez et al., 2015). Thus, incorporating these techniques 
(i.e. journals and goal setting) into programming in future studies is essential to motivating 
individuals to partake in regular exercise (Bourke et al., 2013). 
The pilot study did not raise any safety concerns for individuals with NSCLC, 
prostate cancer, colorectal cancer, or endometrial cancer. The NPW intervention was well-
tolerated by all participants with no serious adverse events occurring. This is consistent 
with the findings of studies on NPW with individuals diagnosed with cancer (Fields et al., 
2016; Fischer et al., 2015; Jastrzebski et al., 2015; Malicka et al., 2011; Sprod et al., 2005). 
Group NPW sessions were not feasible during the pilot study because of the small 
sample size. Individuals with NSCLC were especially eager to have participants with a 
similar diagnosis take part in the NPW program alongside them. This may be due to a 
general lack of social opportunities for this population, since there are limited support 
groups and programing available to them. It is well known that social support is linked to 
increased physical activity participation in individuals with cancer (Barber, 2012; McNeill, 
Kreuter, & Subramanian, 2006) and for this reason future studies should consider the 
benefit that participants would have from socializing as a group during the NPW sessions.  
The structure of the supervised NPW sessions was successful and participants were 
able to commit to between 20 to 70 minutes of NPW on a regular basis. Participants were 
able to master the NPW technique with guidance from instructors and regular practice. 
Providing time for participants to learn the correct technique the week before starting the 
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NPW program is essential because this gives participants the chance to become more co-
ordinated and comfortable before starting the program (Figard-Fabre, Fabre, Leonardi, & 
Schena, 2010).  
Instructors identified a disparity between the endurance levels of participants with 
NSCLC and participants diagnosed with other types of cancer. Participants with NSCLC 
experienced a significant amount of dyspnea, which caused them to walk at a slower pace.  
For this reason, it is recommended that future NPW programs for individuals with NSCLC 
be organized alongside programs for individuals with other chronic respiratory diseases 
who experience similar symptoms and may be able to relate. This has been done before. 
Glattki et al. (2012) successfully integrated NSCLC patients into a pulmonary 
rehabilitation program for patients with other chronic respiratory diseases determining that 
the rehabilitation programs did help to improve the exercise capacity and pulmonary 
function of NSCLC patients. In addition, NPW may be an ideal type of exercise for 
individuals with NSCLC since studies on individuals with chronic obstructive pulmonary 
disease (COPD) have found that participants who used NPW experienced a significantly 
higher VO2 compared to standard walking without increased breathlessness (Barberan-
Garcia et al., 2015). This demonstrates that NPW may be able to generate higher intensities 
of training with similar perceived effort (Barberan-Garcia et al., 2015). 
Nordic pole walking instructor training is recommended for anyone who will be 
leading the NPW program. Without proper training, instructors will not have the skills 
necessary to properly prescribe a NPW program, progress that program, and teach the NPW 
technique. Less qualified instructors pose a potential safety risk to participants and also has 
the potential to lower the effectiveness of the intervention. Training should include a 
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combination of theory and practice, allowing new instructors the opportunity to teach and 
correct technique. It may help to have additional follow up sessions with instructors to 
review technique and address any difficulties with instruction. 
The equipment was easily acquired and transported to the study location. Having 
the flexibility to conduct the assessments at various locations was helpful and allowed 
researchers to enroll participants who were located a long way from the recreational 
centres. Considerations should be given to the portability of equipment when selecting 
assessment measures for future studies. On average, the initial assessments took longer 
than expected. Scheduling more time for initial assessments would be ideal so researchers 
are able to listen to and develop a rapport with participants.  Establishing rapport creates a 
mutual understanding, promotes communication, and develops trust. One way to 
accomplish this is through motivational interviewing, where health care professionals work 
with an individual to help them explore and understand the need for and importance to 
change (Tahan & Sminkey, 2012). Having a good relationship with participants helped to 
encourage their continued participation in the NPW program and while some principles of 
motivational interviewing were incorporated (i.e. expression of empathy), it would be 
worthwhile to formally include these in the study. 
While all assessment tasks were able to be successfully and safely completed the 
use of the 6MWT, the UULEX, and the FACT-L need to be re-evaluated before conducting 
a large-scale trial.  During the 6MWT participants seemed to reach a point where they 
could not walk any faster. Participants with NSCLC were limited due to dyspnea, while for 
participants with greater functional exercise capacity, it did not seem possible that they 
could walk any faster. Studies examining the individuals with NSCLC should consider 
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focusing on assessing daily physical activity levels, since this may be more effective in 
capturing the overall improvement in endurance as a result of NPW participation. For 
participants with other types of cancer who have a tendency to have greater functional 
exercise capacity (i.e. individuals with prostate cancer) other more rigorous submaximal 
exercise tests should be examined.  
With regards to the UULEX, one participant with NSCLC experienced pain when 
the bar was raised past a certain height causing a pull where there was a scar from lung 
resection surgery. Since this pain may be common in individuals who have had lung 
resection surgery the UULEX may not be a good outcome measure for this group. 
Finally, in this particular study using the FACT-L as a cancer-specific HRQoL 
questionnaire was not ideal since the cancer specific questions did not pertain to the 
participants enrolled in the study. While this questionnaire was included to help examine 
the impact of NPW on cancer specific complications, this type of questionnaire appears to 
be better suited for individuals who are currently undergoing chemotherapy or radiation 
therapy treatments. For studies investigating rehabilitation interventions in the cancer 
population the SF-36 should be used along with questionnaires looking at specific cancer-
related symptoms such as fatigue or anxiety and depression. If the FACT-L questionnaire 
is used as a measure of HRQoL, it is recommended that the question asking whether 
participants regret smoking in the past be removed, since participants found it to be highly 
offensive. 
Incorporating a NPW program for individuals with cancer into a clinical or 
community setting may be beneficial. As a health care practitioner or exercise professional 
obtaining a NPW instructor certification is easily done and the certification is not restricted 
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to a specific health care practitioner. NPW is a cost-effective exercise option that can be 
adapted to meet the needs of various clinical or community settings. The different aspects 
of programming discussed within this paper were in the context of research. However, a 
NPW program for individuals with cancer can easily be applied in the clinical or 
community setting with consideration given to earlier recommendations regarding 
recruitment, space, assessment, program design, and instruction. 
5.2 Outcome Measures 
The NPW group tended to have improved overall physical activity levels and 
HRQoL measures after eight-weeks of NPW. A significant decrease in thigh circumference 
and increase in lower body physical function (30-s sit to stand test) were found (p<0.05). 
The following is an interpretation of these results including advice for future research 
studies. 
We found that physical activity levels among participants in the NPW group 
improved over the duration of the study. We observed an increase in the endurance levels 
of participants who completed the eight-week NPW program. In the systematic review by 
Fritschi et al. (2012a) NPW was recognized for its ability to improve the physical activity 
levels of individuals with COPD and diabetes. Increased physical activity levels in cancer 
patients are linked to improved patient outcomes, decreased mortality, and reduced cancer 
recurrence rates (Arem et al., 2015; Rock et al., 2012).  
Researchers in oncology have recognized the value of physical activity monitors 
(e.g., pedometers and accelerometers) and advocate for their use in this population (Beg, 
Gupta, Stewart, & Rethorst, 2017; D.; Santa Mina, 2017). Physical activity monitors enable 
researchers to capture data beyond measuring step count, including variability, minutes and 
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intensity of activity, energy expenditure, and hours spent sitting, standing, or lying down 
(Beg et al., 2017). Wearable fitness tracking devices (e.g., Fitbit) also have a social 
component that allows users to compare their progress and compete to obtain common 
goals making them a motivational tool (Beg et al., 2017; D.; Santa Mina, 2017). Prior to 
regular use of these devices in studies and clinical programs more research is needed to 
determine the most suitable measures for the cancer population (Beg et al., 2017). We did 
not use wearable monitors, but we recommend their deployment in future studies, since 
questionnaires are prone to errors, self-reporting bias, as well as recall bias. 
Another prominent trend identified within the study was the improvement of 
HRQoL in the participants in the NPW group compared to the control group. 
Advancements in technology related to cancer diagnosis and treatment mean that 
individuals are living longer after diagnosis. A longer life-expectancy is generally positive; 
however, individuals often experience cancer and treatment related symptoms that greatly 
impact their HRQoL. In the pilot study, the NPW group showed improvement in domains 
measuring emotional health, emotional well-being, and energy and fatigue compared to the 
control group who declined in these domains. This is important considering that depression 
and cancer-related fatigue are two of the side effects have been found to impact the HRQoL 
of cancer patients the most (Shi et al., 2011). Systematic reviews on fatigue and HRQoL 
outcomes support these results (Cramp & Byron-Daniel, 2012; Mishra et al., 2012). Cramp 
and Byron-Daniel (2012) conducted a systematic review (56 studies, n=4068) and 
concluded that aerobic exercise is beneficial for individuals with breast and prostate cancer 
who experience cancer-related fatigue during or post cancer treatment. Mishra et al. (2012) 
(40 studies, n=3694) discovered that for individuals who have been diagnosed with cancer, 
122 
 
exercise may improve the HRQoL and specific HRQoL domains including emotional well-
being (Mishra et al., 2012). A significant improvement of the change in emotional well-
being scores at 12-weeks (n=617) was found when researchers conducted a meta-analysis 
comparing individuals who exercised with those in the control interventions (SMD 0.33; 
95% CI 0.05to 0.61) (Mishra et al., 2012). In addition, Cheville et al. (2013) conducted an 
RCT and also found an improvement in fatigue levels in adults with stage IV lung or 
colorectal cancer (n=66) after participating in an eight-week incremental walking and 
home-based strengthening program compared to controls. Considering the importance and 
challenge of maintaining HRQoL in the cancer population after diagnosis, as well as the 
trend towards improvement in HRQoL in this pilot study, a large-scale RCT should 
continue to include HRQoL as an outcome measure and the focus should be placed on 
cancer-specific patient important outcomes (i.e. fatigue).  
We observed a significant decrease in thigh circumference from the baseline to the 
final assessment in the NPW group. Since no other notable changes in body weight or 
circumference measurements occurred over the eight-week period and the change in thigh 
circumference was very small, the observed changes likely resulted from measurement 
error. Furthermore, we are not aware of any other RCTs on NPW that have noticed this 
change (Fritschi et al., 2012a) and there was no change in the 6MWT. It is recommended 
that only waist circumference be measured in future studies. The other circumference 
measurements are likely not routinely meaningful to this population, also other studies do 
not typically take circumference measurements, and there are no set international standards 
in place taking for these measures. 
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The NPW group also experienced a significant improvement in the 30-s chair stand 
test indicating improvement in the lower body strength of these participants. A feasibility 
study examining the impact of an individualized exercise program (with the goal of 
improving recreational aerobic physical activity) on individuals with high-risk colon 
cancer (n=273) showed similar results (Courneya et al., 2016). Individuals were randomly 
allocated to the structured exercise program (n=136) or the health education materials 
group (n=137) (Courneya et al., 2016). After one year of being enrolled in the study, 
individuals taking part in the exercise program experienced a significant increase in the 30-
s chair stand test compared to the health education group (mean between group difference: 
+1.6 repetitions; 95% CI: +0.6 - +2.7; p<0.001) (Courneya et al., 2016). In addition, 
participants in the structured exercise group reported an increase in recreational physical 
activity (mean between group difference: +10.5; 95% CI: +3.1 to +17.9; p=0.002), 
predicted VO2max (mean between group difference: +2.2, 95% CI: -4.6 to +9.1; p=0.068), 
6MWT (mean between group difference: +29; 95% CI: +0.4 to +57; p<0.001), 8-foot-up-
and-go, (mean between group difference: -0.4 seconds; 95% CI: -0.7 to -0.2, p=0.004) and 
sit and reach (mean between group difference: +2.1 centimeters; 95% CI: -0.6 to +4.7; 
p=0.08) (Courneya et al., 2016). No differences were reported in body weight, hip and 
waist circumference, or upper body functioning measures (Courneya et al., 2016). 
Additional trials using similar outcome measurement would help explain the finding of 
improved lower body strength.  
Future studies should focus on cancer specific patient important outcomes. NPW is 
unique, especially for the cancer population that commonly experiences substantial 
deconditioning. By walking with the poles an individual is engaging the upper body and 
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this may result in a difference in muscular endurance. Particularly for individuals 
diagnosed with NSCLC, using Nordic walking poles may help them to overcome 
functional limitations caused by significant deconditioning and shortness of breath. Also, 
many individuals with NSCLC have also been diagnosed with COPD. A study was 
completed to examine how NPW affects the physiological response and RPE of individuals 
with COPD (n=15) (Barberan-Garcia et al., 2015). Results showed that when participants 
used the Nordic poles on solid ground they experienced a significantly higher VO2 
(6MNPWground: 21ml/kg/min ± 3, p<0.05) compared to standard walking, without an 
increase in breathlessness (6MNPWground RPE: 4.2 ±2.0; 6MWT RPE: 4.1 ±1.8) (Barberan-
Garcia et al., 2015). This demonstrates NPW may be able to generate higher intensities of 
training with similar perceived effort (Barberan-Garcia et al., 2015). Findings obtained 
from outcome measures that are most relevant and specific to the cancer population have 
the potential to provide us with the greatest understanding, increasing our impact on 
improving the lives of individuals with cancer.  
Any of the improvements in outcome measures may not only be related to exercise, 
but may be linked to the social benefits and supports that occur during exercise 
participation as well. While it was not possible to administer group sessions, participants 
in the NPW group did feel they received support from the NPW instructor on a weekly 
basis. A systematic review by Barber (2012) examining the research (15 correlational, 
descriptive and observational studies; 7 interventional studies) on social support and 
physical activity in the adult cancer population found that 50% of the studies showed a 
significant relationship between social support and physical activity participation. Future 
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research should consider measuring the social benefits of exercise to tease it out from the 
physical benefits. 
5.3 Strengths and Limitations 
 This pilot study focused on feasibility, and was assessed using an established 
framework (Thabane et al., 2010). The process, resource, management, and scientific 
criteria were clearly defined along with the measures that were being used to evaluate them. 
A pilot study provides a first step in investigating a unique application of an intervention. 
By stating the objectives of a pilot study, in an upfront manner, researchers are able to 
provide more detailed evidence and make stronger recommendations to inform large-scale 
trials. The comprehensive design of this pilot study enhances the probability of success of 
a larger RCT and other future studies. The inclusion of a control group in the pilot study, 
although not necessary, provides a more accurate examination of the procedures. 
 This pilot study has several strengths. The adherence rate of participants to the 
NPW program was high. This can be attributed to the individualized NPW prescription in 
conjunction with several behavioural change techniques (e.g. goal setting and self-
monitoring).  Second, because individuals were categorized into NPW prescription groups 
we were able to establish a dose-response relationship. Also, weekly NPW sessions were 
supervised by trained NPW instructors. Weekly contact with instructors ensured 
participants maintained proper NPW technique, held participants accountable to 
completing the NPW on their own, and helped participants overcome any challenges they 
were experiencing during the program (e.g. back pain). NPW was not only well-tolerated 
by participants diagnosed with different types of cancer, individuals stated that they 
enjoyed walking with the poles and all participants purchased a pair of poles to continue to 
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use at home. We managed to establish and maintain positive relationships with community 
recreation centres. Furthermore, the space provided for assessments and NPW was 
generally adequate because if any issues with the space arose, the centres were flexible 
enough to accommodate our needs.  
 One limitation of this pilot study is that the acceptable feasibility outcomes were 
not identified prior to starting the study. Clearly defining primary and secondary feasibility 
outcome expectations would have allowed researchers to more definitively decide whether 
the study was feasible. Instead, upon study completion, researchers reviewed the study 
barriers and facilitators as a whole, resulting in less specific conclusions. 
  Another limitation to this pilot study is the small sample size that was insufficient 
to test hypotheses or thoroughly assess the efficacy and the safety of the NPW intervention 
in those with NSCLC, prostate cancer, colorectal cancer, and endometrial cancer. Our 
interactions with other researchers in this field support the recruitment challenges of this 
population and indicate that research needs to be conducted over a longer period of time to 
achieve a larger sample size. Also, the heterogeneity of the Population, Intervention, 
Comparison and Outcome (PICO) elements within this pilot study make it difficult to 
determine the specific effect that NPW had on the cancer population. The greatest variation 
occurred within the study population, since individuals were diagnosed with different types 
of cancer that caused them to experience drastically different symptoms affecting their 
physical capacity to varying degrees.  
The short follow-up period is an additional limitation that does not allow us to 
determine if the effects of NPW could be sustained long-term. Studies have shown 
improvement in eight-week exercise interventions; however, more time may be needed to 
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establish a permanent behaviour change of regular exercise participation. The self-reported 
items used to assess physical activity levels and HRQoL may be subject to bias. As 
discussed, the provision of certain devices designed to track physical activities (e.g., 
pedometers, accelerometers) would enable collection of more standardized measures and 
avoid the issues associated with biases resulting from self-reporting. Researchers 
conducted all of the assessments and acted as NPW instructors through the duration of the 
study and this may have led to unintended bias. Also, anthropometric measures may be 
subject to measurement error since results are not supported by other studies. Before 
conducting a large-scale RCT, the technique of taking anthropometric measures should be 































In conclusion, the pilot study indicates that examining the effects of NPW on 
individuals with NSCLC, prostate cancer, colorectal cancer, and endometrial cancer is 
feasible with modifications. Recruitment through cancer centres within hospitals or 
through cancer support groups (rather than posters, social media, and snowball referrals) 
were shown to be the best methods. NPW was well-tolerated by participants despite the 
various cancer and treatment-related side effects they experienced. Prescribing an 
individualized NPW program and integrating behaviour change techniques into the 
program design contributed to strong adherence to the regime. Future research should focus 
on the effects of NPW on HRQoL and physical activity levels of patients with cancer.  In 
addition, more accurate methods for measuring physical activity such as pedometers or 
accelerometers should be used. It is recommended that NPW programs for individuals with 
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Appendix C – Program Evaluation Survey 
 
PART I -- INSTRUCTIONS: Please circle the response that best captures your agreement 
with the following statements regarding the Nordic pole walking (NPW) program. . .  
 Agree Disagree 
1.   Fatigue strongly affected my ability to complete the NPW 
program. 
1 2 3 4 5 
2.   I did not have enough time to complete the NPW program. 1 2 3 4 5 
3.   I was very anxious about my ability to complete the NPW 
program. 
1 2 3 4 5 
4.   I am very motivated to continue the NPW program. 1 2 3 4 5 
5.   I found it very difficult to manage (e.g., schedule time for, 
travel to, etc.) the group NPW session.  
1 2 3 4 5 
6.   I found it very difficult to manage (e.g., schedule time for, 
motivate myself etc.) the NPW session independently. 
1 2 3 4 5 
7.   The NPW program was very demanding. 1 2 3 4 5 
8.   Participating in the NPW program was very beneficial to 
me. 
1 2 3 4 5 
9.   The NPW program is very relevant to individuals with 
cancer who are undergoing treatment  
1 2 3 4 5 
10.  I am in good physical condition. 1 2 3 4 5 
11.  My quality of life has improved significantly since I started 
the NPW program. 
1 2 3 4 5 
12.  My fitness level has improved significantly since I started 
the NPW program. 
1 2 3 4 5 
13.  My anxiety has improved significantly since I started the 
NPW program. 
1 2 3 4 5 
14.  I would strongly recommend this NPW program to a 
friend/colleague with lung cancer. 
1 2 3 4 5 
15.  I was very satisfied with the NPW program. 1 2 3 4 5 
16.  I followed the prescribed NPW program closely. 1 2 3 4 5 
152 
 
17.  I successfully mastered the NPW technique. 1 2 3 4 5 
18.  The NPW instructors were well informed and able to help 
me with my NPW technique. 
1 2 3 4 5 
19.  The NPW group classes were well organized. 1 2 3 4 5 
20.  The NPW journal was very informative and useful. 1 2 3 4 5 
21.  The follow up phone calls/emails helped me to adhere to 
the NPW program. 
1 2 3 4 5 
22.  I intend to continue NPW now that I have completed the 
study. 
1 2 3 4 5 
 
PART II -- INSTRUCTIONS: What follows are some open-ended questions that will 
allow you to elaborate on certain ideas from the first section.  Please use as little or as 
much space as you think you need. 
















Appendix D – Call Tracking Document 
 
TO BE FOLLOWED UP 
No Call Date Recruitment Method 
   
   
   
   
 












t Date  
Compl
ete? 






          
          
          








    
    
    





Appendix E – Exercise Logs 
 
ID #: _______________________   WEEK:___________  
 
GOAL: Time: __________    Rate of Perceived Exertion (RPE): ______   
**Aim to walk 4 times/week (including group session)** 
 
 DAY 1 DAY 1 DAY 1 DAY 1 DAY 1 DAY 1 DAY 1 
TIME 
eg. 10 min  
       
DISTANCE 
eg. 1 km 





































































































Appendix F – Patient Information Tracking Document 
 
Patient Information 
Study ID First Name Last Name 
   
 
Patient Information 
Sex Age Primary Phone Number Second Phone Number Address 
     
 
Patient Information 
Email Preferred Contact Method for 





    
 
Patient Information 
Date of Initial 
Assessment 










     
 
Status 
Active/Inactive Week Follow Up 
(Y/N/W) 
Time it took for Follow Up 
    
 
Status 
Follow Up Notes Reason for Inactive (Withdrawn from 






Appendix G – Expense Tracking Document 
 
OFFICE 
No DATE ITEM COST Comments 
     
 
FACILITY 
No DATE ITEM COST Comments 
     
 
OTHER 
No DATE ITEM COST Comments 





Appendix H – Initial Assessment Data Collection Document 
 
Date:_________________  ID #: __________________ 
Assessment Conducted by: _________________ Time Assessment Started:_________ 
o   Consent Form Completed 
o   Demographics Intake Form 
o   International Physical Activity Questionnaire (short version) 
o   Physical Measures:  
(participant removes shoes and wears as little clothing as possible) 
 
Height 
(stand with back to wall) 
 
            cm 
Weight  
                     kg 
Waist 
(top of iliac crest) 
 
            cm 
Hips 
(max posterior 
extension of buttocks) 
 
                     cm 
Bicep 
(midway b/w acromion & 
olecranon) 
 
            cm 
Thigh 
(90o knee flex, midway 
b/w inguinal crease & 
patella) 
 
                     cm 
Chest 
(4th costosternal joint) 
 
            cm 
Resting Heart Rate 
Oxygen Saturation 
                   bpm 
                      % 
 
o   6-minute walk test 
Distance walked in 6 minutes: ____________ 
o   30 second sit to stand test 
# of sit to stands in 30 seconds: ____________ 
o   Unsupported Upper Limb Exercise Test 
Trial 1:   Time:  ___________ Weight: ______________ 
Trial 2:   Time:  ___________ Weight: ______________ 
o   Grip Strength 
 Left Hand Right Hand 
Trial 1   
Trial 2   
Trial 3   
 
o   SF-36 Questionnaire 
o   Do you take part in any planned exercise activity or program? Circle:  YES  /  NO 
If YES, then please indicate type, duration, frequency and intensity (low, medium or high). Use 
other side of assessment form if necessary. 
_______________________________________________________________________________ 
 




Appendix I – Final Assessment Data Collection Document 
 
Date:_________________  ID #: __________________ 
Assessment Conducted by: ________________ Time Assessment Started: _________ 
o   International Physical Activity Questionnaire (short version) 
o   Physical Measures:  
(participant removes shoes and wears as little clothing as possible) 
 
Height 
(stand with back to wall) 
 
            cm 
Weight  
                     kg 
Waist 
(top of iliac crest) 
 
            cm 
Hips 
(max posterior 
extension of buttocks) 
 
                     cm 
Bicep 
(midway b/w acromion & 
olecranon) 
 
            cm 
Thigh 
(90o knee flex, midway 
b/w inguinal crease & 
patella) 
 
                     cm 
Chest 
(4th costosternal joint) 
 
            cm 
Resting Heart Rate 
Oxygen Saturation 
                   bpm 
                      % 
 
o   6 minute walk test 
Distance walked in 6 minutes: ____________ 
o   30 second sit to stand test 
# of sit to stands in 30 seconds: ____________ 
o   Unsupported Upper Limb Exercise Test 
Trial 1:   Time:  ___________ Weight: ______________ 
Trial 2:   Time:  ___________ Weight: ______________ 
o   Grip Strength 
 Left Hand Right Hand 
Trial 1   
Trial 2   
Trial 3   
 
o   SF-36 Questionnaire 
o   Post-program Questionnaire 
o   Did you take part in any planned exercise activity or program in the last 8 weeks? Circle:  YES  /  
NO  If YES, then please indicate type, duration, frequency and intensity (low, medium or high). 








Appendix J – NPW Exercise Prescription – Highly Active Group 
 
This is how you will progress on a weekly basis as you  
participate in the Nordic walking program: 
 
WEEK 1 






































Appendix K – NPW Exercise Prescription – Minimally Active Group 
 
This is how you will progress on a weekly basis as you  
participate in the Nordic walking program: 
 
WEEK 1 






































Appendix L – NPW Exercise Prescription – Inactive Group 
 
This is how you will progress on a weekly basis as you  
participate in the Nordic walking program: 
 
WEEK 1 







































Appendix M – Nordic Pole Walking Instructions 
 
BASIC EQUIPMENT 
1.   Nordic walking poles (loaned to you for the duration of the program) 
2.   indoor walking shoes 
3.   comfortable clothing 





The poles are adjustable to fit the height, stride and arm swing 




The hand-straps are designed to allow for optimal transfer of 
the power from the upper body (shoulders and arms) to the 
poles with a loose hand grip. 
 
 
The rubber boot tip can be used on hard surfaces such as the 
indoor track or outdoor asphalt. The carbide steel tips can be 















FOUR STEPS TO LEARN THE NORDIC POLE WALKING TECHNIQUE 
 
                      
       STEP 1 & 2    STEP 3 & 4 
STEP 1: Start walking upright and naturally. 
•   Have your hands open and do not grip the poles. 
•   Start walking keeping your body upright and swinging your arms naturally at your sides.  
•   The poles should be dragging with the tips facing backwards on the ground behind you, following 
your arm swing. 
STEP 2: Increase your walking speed and arm swing slightly. 
•   While increasing your walking speed and arm swing try not to think too much. 
•   Keep your hands open, walk upright and relax. 
•   If you are having difficulty with co-ordination, pause and start your walk from standing still with 
the LEFT arm and RIGHT foot forward. 
STEP 3: Learn to push through your poles. 
•   Hold onto the handle of each pole. 
•   Because of the Nordic pole hand straps you don’t need to hold on very tightly. Keep your grip 
relaxed. 
•   Your arm swings forward from the shoulder joint (still dragging the poles) and pushes backwards 
with a slightly bent elbow. 
•   Do not pick the poles up and place them in-front of you. 
STEP 4: Improve your pole walking technique. 
•   Pick up the poles slightly so that you are not dragging them as you walk (be sure to keep your 
arms straight with a slightly bent elbow). 
•   Maintain a relaxed arm swing from the shoulder continuing to push through the poles as you take 
your arm back.  
COMMON MISTAKES IN NORDIC POLE WALKING TECHNIQUE 
1.   Swinging the poles from the elbows only. 
•   Keep arms “long” – handshake position. 
2.   Gripping poles too tightly. 
•   Loosen grip and focus on pushing into the hand straps. 
3.   Difficulty coordinating arm swing with leg swing. 
•   Pause and start your walk from standing still with the LEFT arm and RIGHT foot 
forward. 
•   Slow your walk down and try not to think too much. Let your natural walking rhythm 
happen. 
THREE KEY THINGS TO FOCUS ON DURING YOUR WALK 
1.   PACE – Keep in mind your rate of perceived exertion. 
2.   POSTURE – Remember to look ahead and stand tall as you are walking with the poles. 




Appendix N – Goal Setting Document 
 
ID #: _____________________________   Date: ______________________________ 
 
Welcome to the Nordic pole walking program! Thank you for participating. If at any time 
you have any questions please contact: 
 
Elise Cunningham at 905.721.8668 ext. 5329 or by email: elise.cunningham@uoit.ca 
 
Taking part in an exercise program is a step towards a healthy lifestyle. Please take the 
time to answer the following questions.  
 












The answers that you have provided are a reminder about your motivation behind joining 
this Nordic pole walking program. Please reflect back on your answers for continued 




Appendix O – Responses to Open-ended Questions in the Program Evaluation 
Survey 
 
What did you like about participating in the NPW program? 
 
•   Excellent! I enjoyed it and it benefited me greatly. 
•   It made me want to exercise and it gave me more energy. 
•   I enjoyed the exercise and incremental weekly challenges that were provided. 
•   Being more active and coordinated. Help and encouragement from instructors. 
•   That it taught me the NPW and that I as corrected to master it. Also, it was long 
enough to teach me a new habit of NPW daily. It is a very natural way of 
exercising to strengthen the whole body. 
 
What challenges did you experience while participating in the NPW program? 
•   I needed to change my technique as I walked with another type of pole years 
prior. 
•   The NPW program helped me overcome some physical back and calf pain, which 
initially made the program more challenging. 
•   Very tired at times so was not as consistent with NWP. Remembering to be aware 
of my posture. 
•   To begin to find time to do the NPW. I needed to change some priorities and it 
was difficult. Also, at the beginning I felt very fatigued and tired. The instructor 
was very helpful to keep me on track and supported me. 
 
How could we improve the NPW program for people with cancer in the future? 
•   Very well set up. I can't think of any improvements.  
•   Having a good instructor sure helps.  
•   No suggestions. I thought it was very well organized and well run. Good job! 
•   Depending on the level of sickness perhaps to start slower (10 min, 15 min, 20 
min /day to start). Also, if possible to encourage a family member to walk 
together (it was very helpful in my case). Dress according to the weather. Rest 
after. 
 
Do you have any additional comments or feedback? 
•   Very happy I joined and have profited greatly from it. 
•   Good program. Made me walk by myself where/when I would normally not have. 
Something to continue with others who do Nordic pole walking? Instructors were 
very helpful, supportive and very encouraging. 
•   I feel very lucky that I noticed the study and was accepted to participate. I believe 
that in a way it changed my life. Now I have an activity which I can continue on a 
daily basis as long as I am able to. It improved not only the physical side, but 
most importantly the mental, emotion - my internal side! I would like to sincerely 
thank the instructors for being such understanding teachers/mentors. 
•   Thank you for organizing the program. I hope that it will continue to keep helping 
people for many years ahead. 
